HOYA Corporation and its Subsidiaries
Consolidated Financial Statements under IFRSs
and Independent Auditor's Report
For the year ended 31 March 2020
HOYA Corporation
Note:
This is an excerpt translation of the "Yukashoken-Houkokusho" for the convenience of oversea stakeholders.
In cases where any differences occur between the English translation and the Japanese original, the Japanese original shall prevail.
Contents | |
Independent Auditor's Report..................................................................................................................................... | 3 |
Consolidated Statement of Financial Position............................................................................................................ | 6 |
Consolidated Statement of Comprehensive Income................................................................................................... | 8 |
Consolidated Statement of Changes in Equity............................................................................................................ | 10 |
Consolidated Statement of Cash Flows....................................................................................................................... | 15 |
Notes to the Consolidated Financial Statements......................................................................................................... | 17 |
1. General information..................................................................................................................................... | 17 |
2. Basis of consolidated financial statements.................................................................................................. | 18 |
3. Significant accounting policies.................................................................................................................... | 20 |
4. Critical accounting judgements and key sources of estimation uncertainty................................................ | 34 |
5. Operating segment information................................................................................................................... | 35 |
6. Property, plant and equipment..................................................................................................................... | 40 |
7. Leases.......................................................................................................................................................... | 44 |
8. Goodwill and intangible assets.................................................................................................................... | 47 |
9. Impairment losses........................................................................................................................................ | 50 |
10. Investments in associates............................................................................................................................. | 53 |
11. Deferred taxes and income taxes................................................................................................................. | 54 |
12. Other financial assets and liabilities............................................................................................................ | 59 |
13. Other assets and liabilities........................................................................................................................... | 61 |
14. Inventories................................................................................................................................................... | 62 |
15. Trade and other receivables......................................................................................................................... | 62 |
16. Interest-bearing debt.................................................................................................................................... | 63 |
17. Retirement benefit plans.............................................................................................................................. | 65 |
18. Provisions.................................................................................................................................................... | 69 |
19. Trade and other payables............................................................................................................................. | 70 |
20. Share capital and other equity items............................................................................................................ | 71 |
21. Financial instruments................................................................................................................................... | 75 |
22. Share-based payments.................................................................................................................................. | 91 |
23. Revenue........................................................................................................................................................ | 94 |
24. Revenue and expenses (excluding finance income and costs)..................................................................... | 96 |
25. Finance income and costs............................................................................................................................ | 98 |
26. Other comprehensive income...................................................................................................................... | 99 |
27. Earnings per share....................................................................................................................................... | 101 |
28. Non-cash transactions.................................................................................................................................. | 102 |
29. Subsidiaries.................................................................................................................................................. | 103 |
30. Related party disclosures............................................................................................................................. | 110 |
31. Business combinations................................................................................................................................. | 112 |
32. Contingent liabilities.................................................................................................................................... | 112 |
33. Commitments for expenditure..................................................................................................................... | 112 |
34. Subsequent events........................................................................................................................................ | 112 |
35. Approval of financial statements................................................................................................................. | 113 |
- 2 -
INDEPENDENT AUDITOR'S REPORT
To the Board of Directors of HOYA CORPORATION:
Opinion
We have audited the consolidated financial statements of HOYA CORPORATION and its subsidiaries (the "Group"), which comprise the consolidated statement of financial position as of March 31, 2020, and the consolidated statement of comprehensive income, consolidated statement of changes in equity and consolidated statement of cash flows for the year then ended, and notes to the consolidated financial statements, including a summary of significant accounting policies, all expressed in Japanese yen.
In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group as of March 31, 2020, and its consolidated financial performance and its consolidated cash flows for the year then ended in accordance with International Financial Reporting Standards ("IFRSs").
Convenience Translation
Our audit also comprehended the translation of Japanese yen amounts into U.S. dollar amounts and, in our opinion, such translation has been made in accordance with the basis stated in Note 2 to the consolidated financial statements. Such U.S. dollar amounts are presented solely for the convenience of readers outside Japan.
Basis for Opinion
We conducted our audit in accordance with auditing standards generally accepted in Japan. Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with the provisions of the Code of Professional Ethics in Japan, and we have fulfilled our other ethical responsibilities as auditors. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Responsibilities of Management and the Audit Committee
Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with IFRSs, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the consolidated financial statements, management is responsible for assessing the Group's ability to continue as a going concern, disclosing, as applicable, matters related to going concern in accordance with IFRSs and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.
The Audit Committee is responsible for overseeing the Officers and Directors' execution of duties relating to the design and operating effectiveness of the controls over the Group's financial reporting process.
Auditor's Responsibilities for the Audit of the Consolidated Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with auditing standards generally accepted in Japan will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.
As part of an audit in accordance with auditing standards generally accepted in Japan, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks. The procedures selected depend on the auditor's judgement. In addition, we obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
- 3 -
- Obtain, when performing risk assessment procedures, an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group's internal control.
- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.
- Conclude on the appropriateness of management's use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group to cease to continue as a going concern.
- Evaluate whether the overall presentation and disclosures of the consolidated financial statements are in accordance with IFRSs, as well as the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
- Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.
We communicate with the Audit Committee regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.
We also provide the Audit Committee with a statement that we have complied with relevant ethical requirements regarding independence, and communicate with it all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
- 4 -
Interest Required to Be Disclosed by the Certified Public Accountants Act of Japan
Our firm and its designated engagement partners do not have any interest in the Group which is required to be disclosed pursuant to the provisions of the Certified Public Accountants Act of Japan.
23 June 2020
- 5 -
Consolidated Statement of Financial Position
HOYA Corporation and its Subsidiaries
As at 31 March 2020
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | ||
Dollars (Note 2)) | ||||
Notes | As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
ASSETS | ||||
NON-CURRENT ASSETS: | ||||
Property, plant and equipment-net | 6,9,33 | 111,077 | 152,302 | 1,399,448 |
Goodwill | 8,9 | 42,843 | 42,082 | 386,677 |
Intangible assets | 8,33 | 44,308 | 39,796 | 365,667 |
Investments in associates | 10 | 349 | 1,007 | 9,250 |
Long-term financial assets | 12,21 | 44,103 | 45,975 | 422,448 |
Other non-current assets | 13 | 2,960 | 685 | 6,297 |
Deferred tax assets | 11 | 10,162 | 7,990 | 73,415 |
Total non-current assets | 255,802 | 289,836 | 2,663,203 | |
CURRENT ASSETS: | ||||
Inventories | 14 | 78,973 | 78,130 | 717,910 |
Trade and other receivables | 15,21 | 110,847 | 103,339 | 949,547 |
Other short-term financial assets | 12,21 | 3,131 | 1,303 | 11,976 |
Income taxes receivable | 820 | 510 | 4,687 | |
Other current assets | 13 | 20,946 | 19,907 | 182,918 |
Cash and cash equivalents | 21 | 293,397 | 317,982 | 2,921,820 |
Total current assets | 508,113 | 521,171 | 4,788,857 | |
Total assets | 763,915 | 811,008 | 7,452,060 |
- 6 -
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | ||
Dollars (Note 2)) | ||||
Notes | As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
EQUITY AND LIABILITIES | ||||
EQUITY | ||||
Share capital | 20(1) | 6,264 | 6,264 | 57,560 |
Capital reserves | 20(1) | 15,899 | 15,899 | 146,087 |
Treasury shares | 20(2) | (8,319) | (27,963) | (256,945) |
Other capital reserves | 20(2),22 | (7,434) | (8,428) | (77,442) |
Retained earnings | 20(3),34 | 617,459 | 676,058 | 6,212,056 |
Accumulated other comprehensive income/(loss) | (713) | (16,788) | (154,257) | |
Equity attributable to owners of the Company | 623,155 | 645,042 | 5,927,058 | |
Non-controlling interests | 20(4) | 4,552 | (15,777) | (144,968) |
Total equity | 627,707 | 629,265 | 5,782,090 | |
LIABILITIES | ||||
NON-CURRENT LIABILITIES: | ||||
Interest-bearinglong-term debt | 7,16,21 | 904 | 14,472 | 132,977 |
Other long-term financial liabilities | 12,21 | 10,936 | 23,923 | 219,817 |
Retirement benefit liabilities | 17 | 2,770 | 3,203 | 29,428 |
Provisions | 18 | 2,607 | 2,539 | 23,327 |
Other non-current liabilities | 13 | 2,303 | 1,363 | 12,526 |
Deferred tax liabilities | 11 | 4,917 | 3,851 | 35,386 |
Total non-current liabilities | 24,436 | 49,350 | 453,461 | |
CURRENT LIABILITIES: | ||||
Interest-bearingshort-term debt | 7,16,21 | 1,934 | 7,494 | 68,857 |
Trade and other payables | 19,21 | 54,887 | 62,895 | 577,922 |
Other short-term financial liabilities | 12,21 | 646 | 2,824 | 25,944 |
Income tax payables | 8,872 | 17,765 | 163,235 | |
Provisions | 18 | 1,261 | 1,234 | 11,342 |
Other current liabilities | 13 | 44,171 | 40,181 | 369,209 |
Total current liabilities | 111,772 | 132,393 | 1,216,509 | |
Total liabilities | 136,208 | 181,743 | 1,669,970 | |
Total equity and liabilities | 763,915 | 811,008 | 7,452,060 |
- 7 -
Consolidated Statement of Comprehensive Income
HOYA Corporation and its Subsidiaries
For the year ended 31 March 2020
Continuing operations
Revenue:
Sales
Finance income
Other income
Total revenue
Expenses:
Changes in goods, products and work in progress
Raw materials and consumables used
Employee benefits expense
Depreciation and amortisation
Subcontracting cost
Advertising and promotion expense
Commissions expense
Impairment losses
Finance costs
Share of loss of associates
Foreign exchange (gain)/loss ,net
Other expenses
Total expenses
Profit before tax
Income tax expense
Profit for the year from continuing operations
Profit for the year
Other comprehensive income/(loss):
Items that will not be reclassified subsequently to profit or loss:
Financial assets measured at fair value through other comprehensive income
Remeasurements of the net defined benefit asset and liability, net Income tax relating to components of other comprehensive income/
(loss) Subtotal
Items that may be reclassified subsequently to profit or loss: Exchange differences on translation of foreign operations Share of other comprehensive income of associates
Income tax relating to components of other comprehensive income Subtotal
Total other comprehensive income/(loss) Total comprehensive income/(loss) for the year
(Thousands of | |||
(Millions of Yen) | (Millions of Yen) | U.S. Dollars (Note | |
2)) | |||
For the year ended | For the year ended | For the year ended | |
Notes | |||
31 March 2020 | 31 March 2020 | ||
31 March 2019 |
23 | 565,810 | 576,546 | 5,297,677 |
25 | 2,773 | 3,461 | 31,806 |
24 | 3,775 | 2,463 | 22,627 |
572,359 | 582,470 | 5,352,111 | |
(2,763) | |||
1,003 | 9,215 | ||
86,977 | 93,381 | 858,042 | |
17,22,24 | 132,006 | 133,734 | 1,228,834 |
6,7,8,24 | 26,416 | 34,374 | 315,848 |
5,376 | 4,657 | 42,796 | |
12,719 | 12,214 | 112,231 | |
24 | 34,051 | 33,723 | 309,865 |
9 | 1,099 | 300 | 2,760 |
7,17,25 | 391 | 791 | 7,264 |
10 | 1,113 | 1,652 | 15,182 |
24 | 2,307 | 1,606 | 14,755 |
6,7,8,24 | 128,010 | 117,768 | 1,082,127 |
427,702 | 435,202 | 3,998,919 | |
144,657 | 147,268 | 1,353,192 | |
11 | 22,584 | 32,681 | 300,295 |
122,072 | 114,587 | 1,052,898 | |
122,072 | 114,587 | 1,052,898 | |
26 | |||
809 | 933 | 8,570 | |
17 | (293) | (50) | (463) |
11 | (146) | (212) | (1,949) |
371 | 670 | 6,158 | |
6,612 | (16,806) | (154,420) | |
10 | (16) | 76 | 701 |
11 | 124 | (203) | (1,863) |
6,720 | (16,932) | (155,583) | |
7,091 | (16,262) | (149,424) | |
129,164 | 98,325 | 903,473 |
- 8 -
Profit attributable to:
Owners of the Company
Non-controlling interests
Total
Total comprehensive income/(loss) attributable to: Owners of the Company
Non-controlling interests Total
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |
Dollars (Note 2)) | |||
For the year ended | For the year ended | For the year ended | |
Notes | |||
31 March 2020 | 31 March 2020 | ||
31 March 2019 |
122,103 | 114,406 | 1,051,239 |
(31) | 181 | 1,659 |
122,072 | 114,587 | 1,052,898 |
129,334 | 98,364 | 903,833 |
(171) | (39) | (360) |
129,164 | 98,325 | 903,473 |
(Yen) | (Yen) | (U.S. Dollars (Note | ||
2)) | ||||
Notes | For the year ended | For the year ended | For the year ended | |
31 March 2019 | 31 March 2020 | 31 March 2020 | ||
Basic earnings per share | 27 | |||
Continuing operations | 321.55 | 303.27 | 2.79 | |
Discontinued operations | - | - | - | |
Basic earnings per share | 321.55 | 303.27 | 2.79 | |
Diluted earnings per share | 27 | |||
Continuing operations | 320.96 | 302.74 | 2.78 | |
Discontinued operations | - | - | - | |
Diluted earnings per share | 320.96 | 302.74 | 2.78 |
- 9 -
Consolidated Statement of Changes in Equity
HOYA Corporation and its Subsidiaries
For the year ended 31 March 2020
(Millions of Yen) | ||||||
Notes | Share capital | Capital reserves | Treasury shares | Other capital | Retained earnings | |
reserves | ||||||
Balance at 1 April 2018 | 6,264 | 15,899 | (10,886) | (6,660) | 529,818 | |
Total comprehensive income/(loss) for the year | ||||||
Profit for the year | 122,103 | |||||
Other comprehensive income/(loss) | 26 | |||||
Total comprehensive income/(loss) for the year | 122,103 | |||||
Transactions with owners | ||||||
Contributions by and distributions to owners | ||||||
Acquisition of treasury shares | 20(2) | (2) | - | |||
Disposal of treasury shares | 20(2) | 2,569 | (969) | |||
Dividends, 90 yen per share | 20(3) | (34,164) | ||||
Change in non-controlling interests | 20(4) | - | ||||
Share-based payments (stock options) | 22 | 195 | ||||
Transfer to retained earnings | (297) | |||||
Total contributions by and distributions to | ||||||
owners | - | - | 2,567 | (774) | (34,462) | |
Total transactions with owners | - | - | 2,567 | (774) | (34,462) | |
Balance at 31 March 2019 | 6,264 | 15,899 | (8,319) | (7,434) | 617,459 | |
Cumulative effect of accounting change | 533 | |||||
Restated balance at April 1, 2019 | 6,264 | 15,899 | (8,319) | (7,434) | 617,992 | |
Total comprehensive income/(loss) for the year | ||||||
Profit for the year | 114,406 | |||||
Other comprehensive income/(loss) | 26 | |||||
Total comprehensive income/(loss) for the year | 114,406 | |||||
Transactions with owners | ||||||
Contributions by and distributions to owners | ||||||
Acquisition of treasury shares | 20(2) | (44,261) | (22) | |||
Disposal of treasury shares | 20(2) | 2,309 | (1,032) | |||
Cancellation of treasury shares | 20(2) | 22,308 | (22,308) | |||
Dividends, 90 yen per share | 20(3) | (34,064) | ||||
Change in non-controlling interests | 20(4) | (65) | ||||
Share-based payments (stock options) | 22 | 125 | ||||
Transfer to retained earnings | 32 | |||||
Total contributions by and distributions to | ||||||
owners | - | - | (19,644) | (994) | (56,340) | |
Total transactions with owners | - | - | (19,644) | (994) | (56,340) | |
Balance at 31 March 2020 | 6,264 | 15,899 | (27,963) | (8,428) | 676,058 |
- 10 -
(Millions of Yen)
Notes | |
Balance at 1 April 2018 | |
Total comprehensive income/(loss) for the year | |
Profit for the year | |
Other comprehensive income/(loss) | 26 |
Total comprehensive income/(loss) for the year | |
Transactions with owners | |
Contributions by and distributions to owners | |
Acquisition of treasury shares | 20(2) |
Disposal of treasury shares | 20(2) |
Dividends, 90 yen per share | 20(3) |
Change in non-controlling interests | 20(4) |
Share-based payments (stock options) | 22 |
Transfer to retained earnings | |
Total contributions by and distributions to | |
owners | |
Total transactions with owners | |
Balance at 31 March 2019 | |
Cumulative effect of accounting change | |
Restated balance at April 1, 2019 | |
Total comprehensive income/(loss) for the year | |
Profit for the year | |
Other comprehensive income/(loss) | 26 |
Total comprehensive income/(loss) for the year | |
Transactions with owners | |
Contributions by and distributions to owners | |
Acquisition of treasury shares | 20(2) |
Disposal of treasury shares | 20(2) |
Cancellation of treasury shares | 20(2) |
Dividends, 90 yen per share | 20(3) |
Change in non-controlling interests | 20(4) |
Share-based payments (stock options) | 22 |
Transfer to retained earnings | |
Total contributions by and distributions to | |
owners | |
Total transactions with owners | |
Balance at 31 March 2020 |
Financial assets | Exchange differences | Remeasurements of | Share of other | Accumulated other |
measured at fair value | the net defined | |||
on translation of | comprehensive | comprehensive | ||
through other | benefit liability | |||
foreign operations | income of associates | income/(loss) | ||
comprehensive income | (asset) | |||
378 | (6,652) | - | (1,969) | (8,242) |
697 | 6,853 | (303) | (16) | 7,231 |
697 | 6,853 | (303) | (16) | 7,231 |
(6) | 303 | 297 | ||
(6) | - | 303 | - | 297 |
(6) | - | 303 | - | 297 |
1,070 | 201 | - | (1,985) | (713) |
1,070 | 201 | - | (1,985) | (713) |
715 | (16,805) | (29) | 76 | (16,042) |
715 | (16,805) | (29) | 76 | (16,042) |
(61) | 29 | (32) | ||
(61) | - | 29 | - | (32) |
(61) | - | 29 | - | (32) |
1,724 | (16,604) | - | (1,909) | (16,788) |
- 11 -
(Millions of Yen) | ||||
Equity | Non-controlling | |||
Notes | attributable to owners | Total equity | ||
interests | ||||
of the Company | ||||
Balance at 1 April 2018 | 526,193 | 4,484 | 530,677 | |
Total comprehensive income/(loss) for the year | ||||
Profit for the year | 122,103 | (31) | 122,072 | |
Other comprehensive income/(loss) | 26 | 7,231 | (140) | 7,091 |
Total comprehensive income/(loss) for the year | 129,334 | (171) | 129,164 | |
Transactions with owners | ||||
Contributions by and distributions to owners | ||||
Acquisition of treasury shares | 20(2) | (2) | (2) | |
Disposal of treasury shares | 20(2) | 1,600 | 1,600 | |
Dividends, 90 yen per share | 20(3) | (34,164) | (30) | (34,195) |
Change in non-controlling interests | 20(4) | - | 269 | 269 |
Share-based payments (stock options) | 22 | 195 | 195 | |
Transfer to retained earnings | - | - | ||
Total contributions by and distributions to | ||||
owners | (32,372) | 238 | (32,134) | |
Total transactions with owners | (32,372) | 238 | (32,134) | |
Balance at 31 March 2019 | 623,155 | 4,552 | 627,707 | |
Cumulative effect of accounting change | 533 | 533 | ||
Restated balance at April 1, 2019 | 623,688 | 4,552 | 628,240 | |
Total comprehensive income/(loss) for the year | ||||
Profit for the year | 114,406 | 181 | 114,587 | |
Other comprehensive income/(loss) | 26 | (16,042) | (220) | (16,262) |
Total comprehensive income/(loss) for the year | 98,364 | (39) | 98,325 | |
Transactions with owners | ||||
Contributions by and distributions to owners | ||||
Acquisition of treasury shares | 20(2) | (44,283) | (44,283) | |
Disposal of treasury shares | 20(2) | 1,277 | 1,277 | |
Cancellation of treasury stock | 20(2) | - | - | |
Dividends, 90 yen per share | 20(3) | (34,064) | - | (34,064) |
Change in non-controlling interests | 20(4) | (65) | (20,289) | (20,354) |
Share-based payments (stock options) | 22 | 125 | 125 | |
Transfer to retained earnings | - | - | ||
Total contributions by and distributions to | ||||
owners | (77,011) | (20,289) | (97,300) | |
Total transactions with owners | (77,011) | (20,289) | (97,300) | |
Balance at 31 March 2020 | 645,042 | (15,777) | 629,265 |
- 12 -
Consolidated Statement of Changes in Equity
HOYA Corporation and its Subsidiaries
For the year ended 31 March 2020-Continued
(Thousands of U.S. Dollars (Note 2)) | |||||||
Notes | Share capital | Capital reserves | Treasury shares | Other capital | Retained earnings | ||
reserves | |||||||
Balance at 31 March 2019 | 57,560 | 146,087 | (76,441) | (68,311) | 5,673,614 | ||
Cumulative effect of accounting change | 4,895 | ||||||
Restated balance at April 1, 2019 | 57,560 | 146,087 | (76,441) | (68,311) | 5,678,509 | ||
Total comprehensive income/(loss) for the year | |||||||
Profit for the year | 1,051,239 | ||||||
Other comprehensive income/(loss) | 26 | ||||||
Total comprehensive income/(loss) for the year | 1,051,239 | ||||||
Transactions with owners | |||||||
Contributions by and distributions to owners | |||||||
Acquisition of treasury shares | 20(2) | (406,700) | (203) | ||||
Disposal of treasury shares | 20(2) | 21,214 | (9,483) | ||||
Cancellation of treasury shares | 20(2) | 204,982 | (204,982) | ||||
Dividends, 90 yen per share | 20(3) | (313,006) | |||||
Change in non-controlling interests | 20(4) | (597) | |||||
Share-based payments (stock options) | 22 | 1,153 | |||||
Transfer to retained earnings | 296 | ||||||
Total contributions by and distributions to | |||||||
owners | - | - | (180,504) | (9,131) | (517,692) | ||
Total transactions with owners | - | - | (180,504) | (9,131) | (517,692) | ||
Balance at 31 March 2020 | 57,560 | 146,087 | (256,945) | (77,442) | 6,212,056 | ||
(Thousands of U.S. Dollars (Note 2)) | |||||||
Financial assets | Exchange differences | Remeasurements of | Share of other | Accumulated other | |||
Notes | measured at fair value | the net defined | |||||
on translation of | comprehensive | comprehensive | |||||
through other | benefit liability | ||||||
foreign operations | income of associates | income/(loss) | |||||
comprehensive income | (asset) | ||||||
1,851 | (18,238) | (6,556) | |||||
Balance at 31 March 2019 | 9,832 | - | |||||
Cumulative effect of accounting change | |||||||
Restated balance at April 1, 2019 | 9,832 | 1,851 | - | (18,238) | (6,556) | ||
Total comprehensive income/(loss) for the year | |||||||
Profit for the year | |||||||
Other comprehensive income/(loss) | 26 | 6,571 | (154,415) | (263) | 701 | (147,406) | |
Total comprehensive income/(loss) for the year | 6,571 | (154,415) | (263) | 701 | (147,406) | ||
Transactions with owners | |||||||
Contributions by and distributions to owners | |||||||
Acquisition of treasury shares | 20(2) | ||||||
Disposal of treasury shares | 20(2) | ||||||
Cancellation of treasury shares | 20(2) | ||||||
Dividends, 90 yen per share | 20(3) | ||||||
Change in non-controlling interest | 20(4) | ||||||
Share-based payments (stock options) | 22 | ||||||
Transfer to retained earnings | (559) | 263 | (296) | ||||
Total contributions by and distributions to | |||||||
owners | (559) | - | 263 | - | (296) | ||
Total transactions with owners | (559) | - | 263 | - | (296) | ||
Balance at 31 March 2020 | 15,844 | (152,564) | - | (17,538) | (154,257) |
- 13 -
(Thousands of U.S. Dollars (Note 2)) | ||||
Equity | Non-controlling | |||
Notes | attributable to owners | Total equity | ||
interests | ||||
of the Company | ||||
Balance at 31 March 2019 | 5,725,953 | 41,824 | 5,767,777 | |
Cumulative effect of accounting change | 4,895 | 4,895 | ||
Restated balance at April 1, 2019 | 5,730,848 | 41,824 | 5,772,672 | |
Total comprehensive income/(loss) for the year | ||||
Profit for the year | 1,051,239 | 1,659 | 1,052,898 | |
Other comprehensive income/(loss) | 26 | (147,406) | (2,019) | (149,424) |
Total comprehensive income/(loss) for the year | 903,833 | (360) | 903,473 | |
Transactions with owners | ||||
Contributions by and distributions to owners | ||||
Acquisition of treasury shares | 20(2) | (406,904) | (406,904) | |
Disposal of treasury shares | 20(2) | 11,731 | 11,731 | |
Cancellation of treasury shares | 20(2) | - | - | |
Dividends, 90 yen per share | 20(3) | (313,006) | - | (313,006) |
Change in non-controlling interest | 20(4) | (597) | (186,432) | (187,030) |
Share-based payments (stock options) | 22 | 1,153 | 1,153 | |
Transfer to retained earnings | - | - | ||
Total contributions by and distributions to | ||||
owners | (707,623) | (186,432) | (894,055) | |
Total transactions with owners | (707,623) | (186,432) | (894,055) | |
Balance at 31 March 2020 | 5,927,058 | (144,968) | 5,782,090 |
- 14 -
Consolidated Statement of Cash Flows
HOYA Corporation and its Subsidiaries
For the year ended 31 March 2020
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |||
Dollars (Note 2)) | |||||
Notes | For the year ended | For the year ended | For the year ended | ||
31 March 2019 | 31 March 2020 | 31 March 2020 | |||
Cash flows from operating activities | |||||
Profit before tax | 144,657 | 147,268 | 1,353,192 | ||
Depreciation and amortisation | 26,416 | 34,374 | 315,848 | ||
Impairment losses | 1,099 | 300 | 2,760 | ||
Finance income | (2,773) | (3,461) | (31,806) | ||
Finance costs | 391 | 791 | 7,264 | ||
Share of (profits)/loss of associates | 1,113 | 1,652 | 15,182 | ||
(Gain)/loss on sales of property, plant and equipment | (492) | (258) | (2,367) | ||
Loss on disposal of property, plant and equipment | 609 | 375 | 3,444 | ||
Gain on business transfer | (3) | - | - | ||
Foreign exchange (gain)/loss | 342 | (567) | (5,209) | ||
Others | 7,936 | (4,265) | (39,188) | ||
Cash generated from operations (before movements in working | |||||
capital) | 179,294 | 176,209 | 1,619,121 | ||
Movements in working capital | |||||
Decrease/(increase) in inventories | (6,128) | (2,300) | (21,137) | ||
Decrease/(increase) in trade and other receivables | (3,066) | 4,186 | 38,467 | ||
Increase/(decrease) in trade and other payables | 4,985 | 5,152 | 47,337 | ||
Increase/(decrease) in retirement benefit liabilities and provisions | 428 | 433 | 3,978 | ||
Subtotal | 175,512 | 183,680 | 1,687,766 | ||
Interests received | |||||
2,435 | 3,201 | 29,413 | |||
Dividends received | 5 | 14 | 125 | ||
Interest paid | (261) | (511) | (4,700) | ||
Income taxes paid | (31,637) | (23,169) | (212,891) | ||
Income taxes refunded | 533 | 152 | 1,395 | ||
Net cash generated from operating activities | 146,588 | 163,366 | 1,501,108 | ||
Cash flows from investing activities | |||||
Withdrawals of time deposits | 21,815 | 2,804 | 25,763 | ||
Payments for time deposits | (18,223) | (2,367) | (21,748) | ||
Proceeds from sales of property, plant and equipment | 2,340 | 472 | 4,337 | ||
Payments for acquisition of property, plant and equipment | (26,672) | (45,177) | (415,116) | ||
Proceeds from sales of investment | 10 | 1,948 | 17,901 | ||
Payments for acquisition of investment | (27,777) | (1,562) | (14,355) | ||
Proceeds from sales of subsidiaries | 260 | - | - | ||
Payments for acquisition of subsidiaries | (19,742) | (969) | (8,903) | ||
Proceeds from business transfer | 4 | - | - | ||
Payments for business transfer | (421) | (542) | (4,976) | ||
Other proceeds | 427 | 226 | 2,072 | ||
Other payments | (2,164) | (2,217) | (20,370) | ||
Net cash used in investing activities | (70,144) | (47,384) | (435,395) |
- 15 -
Consolidated Statement of Cash Flows
HOYA Corporation and its Subsidiaries
For the year ended 31 March 2020-Continued
Cash flows from financing activities | Notes | |
Dividends paid to owners of the Company | ||
Dividends paid to non-controlling interests | ||
Net decrease in short-term borrowings | 16 | |
Repayments of long-term borrowings | 16 | |
Repayments of lease liabilities | 16 | |
Payments for redemption of bonds | 16 | |
Proceeds from disposal of treasury shares | 20(2) | |
Payments for purchase of treasury shares | 20(2) | |
Proceeds from exercise of stock options | ||
Proceeds from share issuance to non-controlling shareholders | 20(4) | |
Payments for acquisition of non-controlling interests | 20(4) | |
Net cash used in financing activities | ||
Net increase/(decrease) in cash and cash equivalents | ||
Cash and cash equivalents at the beginning of the year |
Effects of exchange rate changes on the balance of cash and cash equivalents in foreign currencies
Cash and cash equivalents at the end of the year Note:
Non-cash transactions are stated in Note 28 "Non-cash transactions".
There are no short-term investments within three months as at 31 March 2020.
- 16 -
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. |
Dollars (Note 2)) | ||
For the year ended | For the year ended | For the year ended |
31 March 2019 | 31 March 2020 | 31 March 2020 |
(34,141) | ||
(34,042) | (312,803) | |
(30) | - | - |
- | (775) | (7,121) |
(271) | (134) | (1,232) |
- | (7,547) | (69,346) |
(14) | - | - |
0 | - | - |
(2) | (44,283) | (406,904) |
1,600 | 1,277 | 11,731 |
67 | 187 | 1,715 |
- | (149) | (1,372) |
(32,792) | (85,468) | (785,332) |
43,652 | 30,514 | 280,381 |
245,835 | 293,397 | 2,695,923 |
3,910 | (5,930) | (54,484) |
293,397 | 317,982 | 2,921,820 |
Notes to the Consolidated Financial Statements
HOYA Corporation and its Subsidiaries
For the year ended 31 March 2020
1. General information
HOYA Corporation (the "Company") is a limited company incorporated in Japan. The addresses of its registered office and principal place of business are disclosed on the Company's website (URL http://www.hoya.com). The principal activities of the Company, its subsidiaries and its associates (the "Group") are described in Note 5 "Operating segment information".
- 17 -
2. Basis of consolidated financial statements
(1) Basis of consolidated financial statements
The accompanying consolidated financial statements have been prepared in accordance with International Financial Reporting Standards ("IFRSs").
The accompanying consolidated financial statements are stated in Japanese yen.
The translations of Japanese yen amounts into U.S. dollar amounts are included solely for the convenience of readers outside Japan using the rate of ¥108.83 to $1, the foreign exchange rate at 31 March 2020. Such translations should not be construed as representations that the Japanese yen amounts could be converted into U.S. dollars at that or any other rate. Amounts of less than one million yen and one thousand U.S. dollars have been rounded to the nearest million yen and one thousand U.S. dollars in the presentation of the accompanying consolidated financial statements. As a result, the totals in yen and U.S. dollars do not necessarily agree with the sum of the individual amounts.
The Company and its domestic subsidiaries maintain their books and prepare their financial statements in accordance with accounting principles generally accepted in Japan ("Japanese GAAP") while its foreign subsidiaries maintain their books and prepare their financial statements in conformity with accounting principles generally accepted in the countries of their domicile. Certain adjustments and reclassifications have been incorporated in the accompanying consolidated financial statements to conform to IFRSs. These adjustments were not recorded in their statutory books and ledgers.
(2) Effects of applying new accounting standards
The Group adopted the following IFRS for the year ended 31 March 2020:
IFRSs | Subject of new standards/amendments and transition provisions | ||
IFRS 16 | Leases | Amendment to the accounting treatment for lease arrangements |
The cumulative effect of initially applying IFRS 16 was recognised at the date of initial application pursuant to a transition method permitted by the standard.
In regard to reassessment, whether a contract is or contains a lease at the date of initial application, the Group chose the practical expedient in paragraph C3 of IFRS 16 and applied IFRS 16 to contracts that had been previously identified as leases applying IAS 17, Leases (hereinafter referred as to "IAS 17"), and IFRIC 4, Determining whether an arrangement contains a lease, and did not apply IFRS16 to contracts that had not. On or after the date of initial application, a lease is identified in accordance with IFRS 16.
A lease liability and a right-of-use asset were recognised at the date of initial application for leases previously classified as operating leases applying IAS 17. A lease liability was measured at the present value of the remaining lease payments, discounted using the lessee's incremental borrowing rate at the date of initial application. This weighted average lessee's incremental borrowing rate is 1.8%. A right-of-use asset was measured at an amount equal to the lease liability, adjusted by the amount of prepaid lease payments for that lease.
The carrying amounts of right-of-use assets and lease liabilities that were previously classified as finance leases applying IAS 17 were measured at the book value immediately before that date of initial application of IFRS16.
The following table shows difference between operating lease commitments disclosed applying IAS 17 at the end of the previous annual reporting period and lease liabilities recognised on the consolidated statement of financial position at the date of initial application.
(millions of yen) | |
Amount | |
Operating lease commitments disclosed at 31 March 2019 | 6,442 |
Lease liabilities of finance lease (31 March 2019) | 862 |
Non-cancelable operating leases etc. | 14,933 |
Lease liabilities at 1 April 2019 | 22,237 |
Right-of-use assets recognised on the consolidated statement of financial position at the date of initial application are ¥25,131 million. The Group used the following practical expedient when applying IFRS 16;
・Initial direct costs are excluded from the measurement of the right-of-use assets at the date of initial application.
- 18 -
(3) Standards and interpretations in issue but not yet adopted by the Group
At the date of approval of the consolidated financial statements, the main standards and interpretations that were issued but not yet effective for mandatory adoption are as follows. There are no standards and interpretations that were early adopted by the Group. The implication from the adoption of the revision of IFRS 16 has not yet been fully assessed by the Group. Except for the revision of IFRS 16, the impact of the adoption of these standards and interpretations on the consolidated financial statements of the Group is immaterial.
Mandatory | To be adopted | ||
adoption | |||
by the Group | |||
IFRSs | (from | ||
from the year | |||
the year | |||
ending | |||
beginning) | |||
IFRS 10 | Consolidated Financial | ||
(Revised) | Statements | Not determined | Not determined |
IAS 28 | Investments in Associates | ||
(Revised) | and Joint Ventures | ||
IFRS 16 | Leases | 1 June 2020 | 31 March 2021 |
(Revised) | |||
Subject of new standards/amendments
Amendments to the accounting treatment for sale or contribution of assets between an investor and its associate or joint venture
Amendments to provide lessees with a practical expedient that relieves a lessee from assessing whether a rent concession is a lease modification in a certain condition
- 19 -
3. Significant accounting policies
(1) Basis of preparation
The consolidated financial statements have been prepared on the historical cost basis except for certain non-current assets and financial instruments measured at revalued amounts or fair value. The principal accounting policies are set out below.
(2) Basis of consolidation
- Subsidiaries
The consolidated financial statements incorporate the financial statements of the Company and entities controlled by the Company as at 31 March of each year. An investor controls an investee when it is exposed or has rights to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee. The Group reassesses whether it controls an investee if facts and circumstances indicate that there are changes to elements of control.
The operating results of the subsidiaries are included in the consolidated statement of comprehensive income from the effective date the Group obtained control of the subsidiaries to the effective date the Group lost control, as appropriate. Where necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those used by other members of the Group. All intragroup transactions, balances, income and expenses are eliminated in full in preparing the consolidated financial statements.
Changes in an interest of a subsidiary without losing control are accounted for as equity transactions. The carrying amounts of the controlling and non-controlling interests are adjusted to reflect the changes in their respective percentage of interests in the subsidiary. If there is a difference between the amount by which the non-controlling interests are adjusted and the fair value of the consideration paid or received, the difference is recognised directly in equity and attributed to the owners of the parent.
If loss in control of a subsidiary occurs, the Group recognises in profit or loss any resulting difference of the following:
- sum of the fair value of any consideration received and any investment retained in the former subsidiary at its fair value; and
- previous carrying amounts of the assets (including goodwill), and liabilities of the subsidiary and any non-controlling interests.
Non-controlling interests in subsidiaries are identified separately from the Group's equity therein. Non-controlling interests consist of those interests at the date of the original business combination and the non-controlling share of changes in equity since the date of the combination. Total comprehensive income is attributed to the owners of the Company and to the non-controlling interests even if this results in the non-controlling interests having a deficit balance.
- Investments in associates
An associate is an entity over which the Group has significant influence and that is neither a subsidiary nor an interest in a joint venture. The results of and the investments in associates are incorporated in the consolidated financial statements using the equity method of accounting, except when the investment is classified as an asset held for sale, in which case it is accounted for in accordance with IFRS 5 "Non-current Assets Held for Sale and Discontinued Operations".
Under the equity method, investments in associates are carried in the consolidated statement of financial position at cost and then adjusted for post-acquisition changes in the Group's share of the net assets of the associates, less any impairment in the value of the investments.
Losses of an associate in excess of the Group's interest in that associate (which includes any long-term interests that, in substance, form part of the Group's net investment in the associate) are recognised only to the extent that the Group has incurred legal or constructive obligations or made payments on behalf of the associate and the excess of those losses is no longer recognised.
- 20 -
Any excess of the cost of acquisition over the Group's share of the net fair value of the identifiable assets, liabilities and contingent liabilities of the associate recognised at the date of acquisition is tested for impairment. Any excess of the Group's share of the net fair value of the identifiable assets, liabilities and contingent liabilities over the cost of acquisition is recognised immediately in profit or loss. When a group entity transacts with an associate of the Group, profits and losses are eliminated to the extent of the Group's interest in the relevant associate.
- Joint arrangements
The Group classifies joint arrangements as either joint operations (having rights to assets and obligations for liabilities accounted for accordingly) or joint ventures (having rights to net assets and equity accounted). The classification depends upon the rights and obligations of the parties to the arrangement.
Joint operators shall account for the assets, liabilities, revenues and expenses relating to their interests in joint operations. Joint ventures shall apply the equity method. The Group has neither joint operations nor joint ventures.
(3) Business combinations
Acquisitions of businesses are accounted for using the acquisition method. Acquisition-related costs are generally recognised in profit or loss as incurred. The acquiree's identifiable assets acquired and liabilities assumed are recognised at their fair values at the acquisition date, except for the following:
- a deferred tax asset or liability arising from the assets acquired and liabilities assumed, and a liability (or asset, if any) related to the acquiree's employee benefit arrangements;
- a liability or an equity instrument related to the replacement of an acquiree's share-based payment awards with share-based payment awards of the acquirer; and
- an asset or disposal group that is classified as held for sale at the acquisition date in accordance with IFRS 5 "Non-current Assets Held for Sale and Discontinued Operations".
When the consideration transferred by the Group in a business combination includes assets or liabilities resulting from a contingent consideration arrangement, the contingent consideration is measured at its acquisition-date fair value and included as part of the consideration transferred in a business combination. Changes in the fair value of the contingent consideration that qualify as measurement period adjustments are adjusted retrospectively, with corresponding adjustments against goodwill. Measurement period adjustments are adjustments that arise from additional information obtained during the "measurement period" (which cannot exceed one year from the acquisition date) about facts and circumstances that existed at the acquisition date.
Changes in the fair value of the contingent consideration resulting from events after the acquisition date are accounted for as follows:
- Contingent consideration classified as equity is not remeasured and any subsequent settlement is accounted for in equity; or
- Contingent consideration classified as an asset or a liability is accounted for in accordance with IAS 37, "Provisions, Contingent Liabilities and Contingent Assets", and IFRS 9, "Financial Instruments", or other IFRSs as appropriate.
Goodwill is measured on the basis of the excess of the sum of the consideration transferred, the amount of any non-controlling interests in the acquiree, and the fair value of the acquirer's previously held equity interest in the acquiree over the fair value of identifiable assets acquired, net of liabilities assumed at acquisition date. Negative goodwill is recognised immediately in profit or loss as a bargain purchase gain.
- 21 -
Non-controlling interests in subsidiaries are reported in equity separately from the equity attributable to owners of the Company. Non- controlling interests are initially measured either at fair value or at the non-controlling interests' proportionate share of the recognised amounts of the acquiree's identifiable net assets on a transaction-by-transaction basis.
When a business combination is achieved in stages, the Group's previously held equity interest in the acquiree is remeasured to the fair value at the acquisition date (i.e., the date when the Group obtains control) and the resulting gain or loss, if any, is recognised in profit or loss. Amounts arising from interests in the acquiree prior to the acquisition date that were previously recognised in other comprehensive income are reclassified to profit or loss where such treatment would be appropriate if that interest were disposed of.
Goodwill arising from business combinations before the IFRSs transition date is measured at carrying amount in accordance with the previous GAAP (i.e., Japanese GAAP) after performing an impairment test.
(4) Foreign currencies
- Foreign currency transactions
The individual financial statements of each group entity are presented in the currency of the primary economic environment in which the entity operates (i.e., its functional currency). For the purpose of the consolidated financial statements, the financial results, financial position and cash flows of each Group entity are presented in Japanese yen, which is the functional currency of the Company and the presentation currency for the consolidated financial statements.
In preparing the financial statements of the individual entities, transactions in currencies other than the entity's functional currency (foreign currencies) are translated at the rates of exchange prevailing at the dates of the transactions.
At the end of each reporting period, monetary items denominated in foreign currencies are translated at the rates prevailing at that date. Non-monetary items carried at fair value that are denominated in foreign currencies are translated at the rates prevailing at the date when the fair value was determined. Exchange differences are recognised in profit or loss during the period.
- Financial statements of foreign operations
The assets and liabilities of foreign operations are translated into Japanese yen at the foreign exchange rates prevailing at the end of the reporting period. The revenues and expenses of foreign operations are translated into Japanese yen at the average rates of exchange for the year. Where there are material fluctuations in exchange rates, the exchange rate at the transaction date is used. Foreign exchange differences arising from translation are initially recognised as exchange differences on translation of foreign operations in other comprehensive income and accumulated in 'accumulated other comprehensive income', which are reclassified from equity to profit or loss on disposal of the net investment and included in 'other expenses' in the consolidated statement of comprehensive income.
- 22 -
(5) Property, plant and equipment
The Group applies the cost model for measuring property, plant and equipment.
Property, plant and equipment are stated at cost, net of accumulated depreciation and impairment losses. Properties in the course of construction for production, supply or administrative purposes, or for purposes not yet determined, are carried at cost, less any recognised impairment losses. Cost includes the expenses directly attributable to the assets; the initial estimated costs relating to scrap, removal and retirement; and, for qualifying assets, the borrowing cost for long-term projects. Depreciation of these assets commences when the assets are available for their intended use.
When significant components of property, plant and equipment are required to be replaced periodically, the Group recognises such components as individual assets to be depreciated with specific useful lives. All other repair and maintenance costs are recognised in profit or loss as incurred.
Property, plant and equipment other than land and construction in progress are depreciated mainly on a straight-line basis over the following estimated useful lives. The estimated useful lives, residual values and depreciation method are reviewed at each year-end, with the effect of any changes in estimate being accounted for on a prospective basis.
Buildings and structures: 3-50 years
Machinery and carriers: 3-10 years
Tools, equipment and fixtures: 2-10 years
(6) Leases
As a lessee, the Group recognises a right-of-use asset and a lease liability at the commencement date. The lease liability is measured at the present value of the lease payments that are not paid at the commencement date. The right-of-use asset is measured at cost comprised of the initial amount of the lease liability adjusted for any lease payments made at or before the commencement date, any initial direct costs incurred and an estimate of costs, such as the cost to dismantle and remove the underlying asset to the original condition required by the terms and conditions of lease contracts.
After the commencement date, the right-of-use asset is depreciated on a straight-line basis over the useful life or lease term, whichever is shorter.
The lease payments comprise of interest expense recognised as finance costs in the consolidated statement of comprehensive income and repayments of the lease liability that are calculated by the interest method. The Group does not recognise right-of-use assets and lease liabilities for short-term leases that have a lease term of 12 months or less and for leases of low-value assets. The Group recognises the lease payments associated with these leases as expense on straight-line basis over the lease term or other systematic basis.
As a lessor, the Group classifies each of its leases as either an operating lease or a finance lease. A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership of an underlying asset. A lease is classified as an operating lease if it does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset.
At the commencement date, the asset held under a finance lease is recognised on the consolidated statement of financial position and presented as a receivable at an amount equal to the net investment in the lease.
The assets held under an operating lease are on the consolidated statement of financial position and the lease payments received are recognised as income on a straight-line basis over the lease term in the consolidated statements of comprehensive income.
- 23 -
(7) Intangible assets
The Group uses the cost model for measuring intangible assets. Intangible assets are carried at cost less accumulated amortisation and impairment losses.
- Intangible assets acquired separately and/or acquired in a business combination
Intangible assets acquired separately are carried at cost at initial recognition. Intangible assets acquired in a business combination are recognised separately from goodwill at their fair value at the acquisition date, when they are satisfied with the definition of intangible assets, identifiable, and their fair value is reasonably measured.
- Internally-generatedintangible assets-research and development ("R&D") costs Expenditures on research activities are recognised as expense in the period in which they are incurred.
An internally-generated intangible asset arising from development (or from the development phase of an internal project) is recognised if, and only if, all of the following have been demonstrated:
- the technical feasibility of completing the intangible asset so that it will be available for use or sale;
- the intention to complete the intangible asset and use or sell it;
- the ability to use or sell the intangible asset;
- how the intangible asset will generate probable future economic benefits;
- the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
- the ability to measure reliably the expenditure attributable to the intangible asset during its development.
The amount initially recognised for internally-generated intangible assets is the sum of the expenses incurred from the date when the intangible assets first meet all of the recognition criteria listed above. The assets are amortised over the estimated period in which the development costs are expected to be recovered. If no future economic benefit is expected before the end of the life of assets, the residual carrying amount is expensed.
Subsequent to initial recognition, internally-generated intangible assets are reported at cost less accumulated amortisation and impairment losses. Where no internally-generated intangible asset can be recognised, development costs are recognised as an expense in the period in which they are incurred.
- Amortisation of intangible assets
Amortisation is recognised on a straight-line basis over the estimated useful lives below. The Group does not have any intangible assets with indefinite useful lives.
Technology: 5-20 years
Customer related assets: 5-16 years
Software: 3-5 years
- Derecognition of intangible assets
An intangible asset is derecognised on disposal or when no future economic benefits are expected from use or disposal. Gains or losses arising from derecognition of an intangible asset are recognised in profit or loss when the asset is derecognised.
- 24 -
(8) Goodwill
Goodwill arising from the acquisition of a business is recognised as an asset at the date that control is acquired (i.e., the acquisition date). Goodwill is measured as the excess of the sum of the consideration transferred, the amount of any non-controlling interests in the acquiree, and the fair value of the acquirer's previously held equity interest in the acquiree (if any) over the acquisition-date amounts of the net fair value of the identifiable assets acquired and the liabilities assumed. Goodwill is not amortised but is reviewed for impairment at least annually. Goodwill is recorded at cost less accumulated impairment losses on the consolidated statement of financial position.
For the purposes of impairment testing, goodwill is allocated to each of the Group's cash-generating units (or groups of cash- generating units) that is expected to benefit from the synergies of the combination. Cash-generating units to which goodwill has been allocated are tested for impairment annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than its carrying amount, the impairment losses are allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit on a pro-rata basis of the carrying amount of each asset in the unit. Impairment losses recognised for goodwill are not reversed in subsequent periods. Upon disposal of a cash- generating unit, goodwill attributed to the unit is included in the determination of the profit or loss upon disposal.
The Group's accounting policy for goodwill arising on the acquisition of an associate is described at "(2) Basis of consolidation - ② Investments in associates" above.
(9) Impairment of property, plant and equipment and intangible assets other than goodwill
At the end of each reporting period, the Group reviews the carrying amounts of its property, plant and equipment and intangible assets to determine whether there are any indications that those assets have suffered impairment losses. If any such indication exists, the recoverable amount of the cash-generating unit to which the asset belongs is estimated in order to determine the extent of the impairment losses (if any).
Where a reasonable and consistent basis of allocation can be identified, corporate assets (i.e., assets other than goodwill that contribute to the future cash flows of both the cash-generating unit under review and other cash-generating units) are also allocated to individual cash-generating units, or otherwise they are allocated to the smallest group of cash-generating units for which a reasonable and consistent allocation basis can be identified.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount.
Where impairment losses subsequently reverse, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, such that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment losses been recognised for the asset (or cash-generating unit) in prior years. A reversal of impairment losses is recognised immediately in profit or loss.
- 25 -
(10) Derivative financial instruments
Derivatives are initially recognised at fair value at the date the derivative contract is entered into and are subsequently remeasured at their fair value at the end of each reporting period.
(11) Financial assets other than derivative financial instruments
- Initial recognition and measurement
Financial assets are classified as "financial assets measured at amortised cost," "financial assets measured at fair value through other comprehensive income" ("FVTOCI") or "financial assets measured at fair value through profit and loss" ("FVTPL"). The classification is determined at the time of initial recognition
The Group recognises a financial asset on the trade date when it becomes party to the contract of the financial asset.
All financial assets are measured at the fair value plus transaction costs, except for FVTPL.
- Financial assets measured at amortised cost
Such financial assets are held within a business model whose objective is to hold financial assets to collect contractual cash flows, and the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.
After initial recognition, "Financial assets measured at amortised cost" are measured at amortised cost by using the effective interest method, less the cumulative amount of impairment losses.
- Financial assets classified as FVTOCI
Such financial assets are measured at fair value through other comprehensive income if both of the following conditions are met:
- the financial asset is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets
- the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding. The change in fair value is recognised in other comprehensive income.
The fair value of a particular asset in an equity instrument for which the Group makes an irrevocable election at initial recognition to present in other comprehensive income subsequent changes in its fair value is recognised in other comprehensive income.
- Financial assets classified as FVTPL
Any other securities not included in the classifications above are classified into financial assets measured at fair value through profit and loss. The change in fair value is recognised in profit or loss.
- Impairment of financial assets
The Group recognises a loss allowance for expected credit losses on "financial assets measured at amortised cost".
The Group assesses whether the credit risk on a financial instrument has increased significantly since initial recognition. If the credit risk on a financial instrument has not increased significantly since initial recognition, the Group measures the loss allowance for that financial instrument at an amount equal to 12-month expected credit losses. If the credit risk on a financial instrument has increased significantly since initial recognition, the Group measures the loss allowance for that financial instrument at an amount equal to the lifetime expected credit losses. For trade receivables, the Group always measures the loss allowance at an amount equal to the lifetime expected credit losses. The Group assesses the expected credit losses by using the change in the risk of a default or ageing of trade receivables, etc. It is recognised in profit or loss.
- Derecognition of financial assets
The Group derecognises a financial asset only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another entity. If the Group retains substantially all the risks and rewards of ownership of a transferred financial asset, the Group continues to recognise the financial asset and a collateralised borrowing for the proceeds received.
- 26 -
(12) Inventories
Inventories are measured at the lower of cost and net realisable value. Net realisable value represents the estimated selling price for the inventories in the ordinary course of business, less all estimated costs of completion and costs necessary to make the sale. Costs, including purchase costs, process costs, storage costs and all other costs incurred in bringing the inventories to their present location and condition, are assigned to inventories mainly by the weighted-average method. The production costs include an appropriate portion of fixed and variable overhead expenses.
(13) Cash and cash equivalents
Cash and cash equivalents are composed of cash on hand and bank deposits including short-term investments. The short-term investments with original maturities of three months or less are deemed as cash equivalents since they are readily convertible to cash without restriction and with low risk of fluctuation of values.
(14) Assets held for sale
Non-current assets and disposal groups are classified as held for sale if their carrying amount will be recovered principally through a sale transaction rather than through continuing use. This condition is regarded as met only when the sale is highly probable and the non-current asset (or disposal group) is available for immediate sale in its present condition. Management must be committed to the sale, which should be expected to qualify for recognition as a completed sale within one year from the date of classification.
When the Group is committed to a sale plan involving loss of control of a subsidiary, all of the assets and liabilities of that subsidiary are classified as held for sale when the criteria described above are met, regardless of whether the Group will retain a non-controlling interest in its former subsidiary after the sale.
Assets classified as held for sale are measured at the lower of their previous carrying amount and fair value less costs to sell. Property, plant and equipment and intangible assets classified as held for sale are not depreciated or amortised after their classification.
- 27 -
(15) Treasury shares
The Group's own equity instruments, which are reacquired (i.e., treasury shares), are recognised at cost and deducted from equity. No gain or loss is recognised on the purchase, disposal or cancellation of the Group's own equity instruments. Any difference between the carrying amount and the consideration given is recognised in other capital reserves.
(16) Share-based payments
Equity-settledshare-based payments (i.e., stock options), which are incentive plans to the Group's directors, officers and certain employees, are measured at the fair value of the equity instruments at the grant date. Details regarding the determination of the fair value of equity-settledshare-based transactions are set out in Note 22 "Share-based payments".
The fair value determined at the grant date of the equity-settledshare-based payments is expensed on a straight-line basis over the vesting period while the corresponding amount to other capital reserves is recognised, based on the Group's estimate of equity instruments that will eventually vest. At the end of each reporting period, the Group revises its estimate of the number of equity instruments expected to vest. The impact of the revision of the original estimates, if any, is recognised in profit or loss such that the cumulative expense reflects the revised estimate, with a corresponding adjustment to other capital reserves.
(17) Dividend distributions
Dividend distributions to the Company's shareholders are recognised as liabilities in the consolidated financial statements in the period in which the dividends are approved by the Company's board of directors.
- 28 -
(18) Financial liabilities issued by the Group excluding derivative instruments
- Financial liabilities
Financial liabilities are classified as either financial liabilities classified as FVTPL or financial liabilities measured at amortised cost. This classification is determined at initial recognition.
- Financial liabilities classified as FVTPL
Financial liabilities classified as FVTPL are either held for trading or designated as FVTPL at initial recognition. They are measured at fair value, and the subsequent changes are recognised in profit and loss.
- Financial liabilities measured at amortised cost
Financial liabilities measured at amortised cost are measured at fair value minus transaction costs at initial recgnition. After the initial recognition, they are measured at amortised cost by using the effective interest method. The gain or loss on cease of amortisation or derecognition is recognised in profit and loss as part of financial costs.
- Derecognition of financial liabilities
The Group derecognises financial liabilities when, and only when, the Group's obligations are discharged, cancelled or expired.
- Financial guarantee contracts
Financial guarantee contracts are initially measured at their fair values and subsequently measured at the higher of:
- the amount of loss allowance for expected credit losses, as determined in accordance with IFRS 9, "Financial Instruments"; and
- the amount initially recognised less cumulative amortisation recognised in accordance with IFRS 15, "Revenue from Contracts with Customers".
- 29 -
(19) Retirement benefit costs
For defined benefit plans, the cost of providing retirement benefits is determined using the projected unit credit method, with actuarial valuations being carried out at the end of each reporting period.
Remeasurement, comprising actuarial gains and losses, the effect of the changes to the asset ceiling (if applicable) and the return on plan assets (other than interest), is reflected immediately in the consolidated statement of financial position with a charge or credit recognised in other comprehensive income in the period in which they occur. Remeasurement recognised in other comprehensive income is reflected immediately in retained earnings and will not be reclassified to profit or loss.
Past service cost is recognised in profit or loss in the period of a plan amendment.
Net interest is calculated by applying the discount rate at the beginning of the period to the net defined benefit liability or asset.
Defined benefit costs are categorised as follows:
- Service cost (including current service cost, past service cost, as well as gains or losses on curtailments and settlements);
- Net interest expense or income; or
- Remeasurement.
The Group presents the first two components of defined benefit cost in profit or loss as "Employee benefits expense" or "Finance cost".
The retirement benefit liabilities recognised in the consolidated statement of financial position represent the actual deficit or surplus in the Group's defined benefit plans. Any surplus resulting from this calculation is limited to the present value of any economic benefits available in the form of refunds from the plans or reductions in future contributions to the plans.
Payments to defined contribution retirement benefit plans are recognised as an expense when employees have rendered service to the Group.
- 30 -
(20) Provisions and contingent liabilities assumed in a business combination
Provisions are recognised when the Group has a present obligation (legal or constructive) as a result of a past event, it is probable that the Group will be required to settle the obligation by outflow of resources embodying economic benefits, and a reliable estimate can be made of the amount of the obligation. The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the end of the reporting period (i.e., future cash outflow), taking into account the risks and uncertainties surrounding the obligation.
Where time value of money is material, a provision is measured at the present value to which estimated future cash flows are discounted using a pre-tax discount rate that reflects the risks specific to the obligation. Interest cost associated with the passage of time is recognised as finance cost.
The types of provisions are as follows:
- Asset retirement obligation
The Group recognises provisions for an asset retirement obligation for estimated costs arising from a contractual obligation to a landlord to dismantle and remove leasehold improvements from a leased office at the end of the lease contract, and estimated costs to decontaminate certain fixed assets. An asset retirement obligation is provided based on past experience of actual cost and each asset is considered individually. The discount rate depends on the useful life of the corresponding assets and the country in which such assets are located. Future expected timing of outflow of economic benefits is mainly more than one year from each reporting period.
- Warranties provision
Warranties provision is estimated and recognised based on past experience of the occurrence of defective goods and the expected after service costs in the warranty period. Expected outflow of economic benefits in the future is within one year from each reporting period.
- Contingent liabilities assumed in a business combination
Contingent liabilities resulting from a business combination are initially measured at fair value at the date of acquisition. Subsequent to initial recognition, such contingent liabilities are remeasured considering expected future payments, possible occurrence and timing of payments at each reporting period.
- 31 -
(21) Revenue
The Group recognises revenue based on the five-step approach below:
Step 1: Identify the contracts with customers
Step 2: Identify the performance obligations in the contract
Step 3: Determine the transaction price
Step 4: Allocate the transaction price to the performance obligations in the contract
Step 5: Recognise revenue when the entity satisfies a performance obligation
The Group sells health care related products, medical related products, electronics related products and imaging related products, etc. Revenue is recognised at the fair value of the consideration received or receivable less discount, rebate and consumption taxes on the shipping or delivery date, or upon the completion of inspection by customers when the control of products is transferred to the customer and the performance obligation is satisfied by the Group.
(22) Government grants
Government grants are measured and recognised at fair value when there is reasonable assurance that the Group will comply with the conditions attached to them and that the grants will be received.
Government grants associated with an expense are recognised as revenue in the same accounting period when the expense is incurred. Government grants for purchase of assets are recognised as deferred revenue in the consolidated statement of financial position and transferred to profit or loss on a systematic basis over the useful lives of the related assets.
- 32 -
(23) Income taxes
Income tax expense represents the sum of the current tax and deferred tax. Current and deferred taxes are recognised in profit or loss, except when they relate to items that are recognised directly in other comprehensive income or equity, or where they arise from the initial accounting for a business combination.
The current tax is calculated based on estimated refund or payment from/to taxation authorities. The Group's current tax liability is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period based on the taxable profit or loss for the Group's operating activity in each country.
Deferred tax is provided using the asset and liability method on temporary differences, tax loss carryforwards and tax credits at the reporting date.
Deferred tax assets or liabilities are not recognised for:
- Temporary differences arising from the initial recognition of goodwill
- Temporary differences arising from the initial recognition of assets and liabilities in transactions that do not affect either accounting profit or taxable profit (excluding business combinations)
- Taxable temporary differences associated with investments in subsidiaries and associates where the timing of the reversal of the temporary differences can be controlled and it is probable that the temporary differences will not reverse in the foreseeable future.
Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets arising from deductible temporary differences are only recognised to the extent that it is probable that there will be sufficient taxable profits against which the benefits of the temporary differences can be utilised and they are expected to reverse in the foreseeable future.
The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Unrecognised deferred tax assets are reassessed at each reporting date and are recognised to the extent that it has become probable that future taxable profits will allow the deferred tax assets to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax assets and liabilities are offset when there is a legally enforceable right to set off the current tax assets against the current tax liabilities and when they relate to income taxes levied by the same tax authority.
In the case of a business combination, the tax effect is included in the accounting for the business combination when measuring the amount of goodwill or determining negative goodwill.
(24) Earnings per share
Basic earnings per share amounts are calculated by dividing net profit for the year attributable to ordinary equity holders of the parent by the weighted-average number of ordinary shares outstanding during the year. Diluted earnings per share amounts are calculated by adjusting profit or loss attributable to ordinary equity holders of the parent and the weighted-average number of ordinary shares outstanding, for the effect of all potential dilutive ordinary shares.
(25) Reclassification
Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
- 33 -
4. Critical accounting judgements and key sources of estimation uncertainty
(1) Application of estimates and assumptions
Preparation of consolidated financial statements requires management to make estimates and assumptions in order to determine the reported amounts of certain assets, liabilities, income and expense items. Regarding the impact of novel coronavirus, the result of Life Care segment is estimated based on the assumption that it will recover after a while later in the end. The result of Information Technology segment is estimated based on the assumption that the impact is short-term.
The following are items that require estimates and assumptions and are considered significant:
- Determination of net realisable value of obsolete inventory (Note 14 "Inventories")
- Expected cash flow from overdue trade and other receivables (Note 21 "Financial instruments")
- Useful lives of property, plant and equipment, right-of-use assets and intangible assets (Note 3 "Significant accounting policies", Note 3 (5) "Property, plant and equipment", Note 3 (6) "Leases" and Note 3 (7) "Intangible assets")
- Lease period of right-of-use assets (Note 3 "Significant accounting policies", (6) "Leases")
- Assumptions used to estimate future cash flows of cash-generating units to assess the recoverability of property, plant and equipment and intangible assets, including goodwill (Note 9 "Impairment losses")
- Financial asset measured at fair value (Note 21 "Financial instruments")
- Recoverability of deferred tax assets (Note 11 "Deferred taxes and income taxes")
- Assumptions used for treatment of retained earnings of overseas subsidiaries and associates for tax purposes (Note 11 "Deferred taxes and income taxes")
- Assumptions used to calculate retirement benefit obligations (Note 17 "Retirement benefit plans")
- Asset retirement obligations arising from legal obligations and constructive obligations (Note 18 "Provisions")
- Fair value of stock options (Note 22 "Share-based payments")
The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from those estimates. The estimates and underlying assumptions are reviewed on an ongoing basis.
Revisions of accounting estimates will affect current and/or future periods.
(2) Key sources of risk and estimation uncertainty
The Group's financial position, financial performance and cash flows are exposed to the following risks and uncertainties:
- Tough competition and excess-supply of inventory in markets in which the Group operates
- Development of new products and timing of development
- Changes in the political, economic and regulatory environment, shortage of labour, labour strikes, natural disasters, and impacts of unexpected international affairs in the countries in which the Group is located and operates
- The effect of deferred taxes and income taxes on transactions between locations in different tax jurisdictions with
different tax rates, or transactions between taxable and tax-exempt businesses (including discrepancies in opinion between the Company and the tax authority)
- Fluctuations of currency exchange rates
- The trend of environmental and governmental regulations
Global economic stagnation and the occurrence of natural disasters may have a significant impact on future profitability of the Group. Future profitability of the Group may affect the estimates for the following:
- Impairment of property, plant and equipment and intangible assets including goodwill (Note 9 "Impairment losses")
- Recoverability of deferred tax assets (Note 11 "Deferred taxes and income taxes")
- 34 -
5. Operating segment information
(1) Overview of major products and services of reportable segments
Reportable segments are components of the Group for which separate financial information is obtained and examined on a regular basis by the board of directors and the chief operating decision maker to determine the allocation of management resources and evaluate the business performance.
In accordance with its management philosophy, the Group has categorised "life and culture" and "information technology" as its business domains. To achieve sustainable growth in corporate value in these business domains, the Group has been making decisions on the allocation of management resources and monitoring the operating results.
As a result, the Group consists of three reportable business segments: the Life Care business, the Information Technology business and Other business, which are consistent with the above business domains.
In the Life Care business, the Group produces and sells health care related products that are used in the health care and medical sectors and medical related products, including medical equipment and medical materials that are used in medical treatments. In operating this business, it is typically a requirement to obtain approvals and permissions in accordance with the Pharmaceutical Affairs Act of Japan and other regulations, and sophisticated technologies and highly reliable quality control systems represent critical elements for operating this business.
In the Information Technology business, the Group has developed an extensive range of products following the digitalisation of information and the emergence of the Internet. The Group produces and sells a broad array of I/O (Input/Output Device) related products in the information and communication sector, including electronics related products that are essential for the modern digital information and communication technologies, and imaging related products that are necessary to import pictures and video images as digital information based on optical technologies.
Other business mainly includes the business that provides information system services and new businesses.
The main products and services for each reportable segment described above are as follows:
Reportable Segment | Major Products and Services | ||
Life Care | Health Care related products | Eyeglass lenses and Contact lenses | |
Medical related products | Endoscopes, Medical accessories, Intraocular lenses, Artificial bone, | ||
Metallic implants for orthopedics | |||
Information Technology | Electronics related products | Photomasks and Maskblanks for semiconductors, | |
Masks and Devices for liquid-crystal displays (LCDs) | |||
Glass disks for hard disk drives (HDDs) | |||
Imaging related products | Optical lenses, Optical glasses, Laser equipment | ||
Other | Design of information systems and other services | ||
- 35 -
(2) Segment revenues and results
The following is an analysis of the Group's revenue and results from continuing operations by reportable segment.
The accounting policies of the reportable segments are the same as the Group's accounting policies described in Note 3 "Significant accounting policies".
(Millions of Yen) | ||||||
For the year ended 31 March | Life Care | Information | Other | Total | Adjustments | Consolidated |
2019 | Technology | |||||
Revenue from external | ||||||
customers | 373,388 | 187,546 | 4,875 | 565,810 | - | 565,810 |
Inter-segment sales | 3 | 96 | 1,511 | 1,610 | (1,610) | - |
Total | 373,391 | 187,643 | 6,386 | 567,420 | (1,610) | 565,810 |
Interest income | 665 | |||||
708 | 3 | 1,376 | 1,387 | 2,763 | ||
Interest expense | (1,475) | (330) | (0) | (1,806) | 1,415 | (391) |
Depreciation and amortisation | (17,349) | (8,478) | (411) | (26,238) | (178) | (26,416) |
Share of profit (loss) of | ||||||
associates | 39 | 20 | - | 59 | (1,172) | (1,113) |
Impairment losses | (690) | (281) | - | (971) | (128) | (1,099) |
Others | (285,291) | (98,685) | (5,240) | (389,216) | (5,682) | (394,897) |
Segment profit before tax | 69,290 | 80,596 | 737 | 150,623 | (5,967) | 144,657 |
Other disclosure | ||||||
Capital expenditure | ||||||
19,108 | 9,933 | 52 | 29,092 | 112 | 29,204 |
Note:
Adjustments to segment profit before tax of (5,967) million yen for the year ended 31 March 2019 consist of elimination of inter- segment transactions of (1) million yen, and profit or loss of the Company's headquarter, the R&D department and overseas holding companies (after elimination of dividend income from Group companies) of (5,966) million yen .
(Millions of Yen) | ||||||
For the year ended 31 March | Life Care | Information | Other | Total | Adjustments | Consolidated |
2020 | Technology | |||||
Revenue from external | ||||||
customers | 375,049 | 196,731 | 4,766 | 576,546 | - | 576,546 |
Inter-segment sales | 3 | 26 | 1,148 | 1,177 | (1,177) | - |
Total | 375,051 | 196,757 | 5,915 | 577,723 | (1,177) | 576,546 |
Interest income | 529 | |||||
944 | 11 | 1,484 | 1,967 | 3,452 | ||
Interest expense | (1,343) | (422) | (1) | (1,766) | 1,154 | (612) |
Depreciation and amortisation | (23,845) | (9,548) | (494) | (33,888) | (486) | (34,374) |
Share of profit (loss) of | ||||||
associates | 69 | 17 | - | 86 | (1,739) | (1,652) |
Impairment losses | (1) | (300) | - | (300) | - | (300) |
Others | (288,230) | (99,314) | (5,399) | (392,942) | (2,849) | (395,791) |
Segment profit before tax | 62,230 | 88,135 | 32 | 150,397 | (3,129) | 147,268 |
Other disclosure | ||||||
Capital expenditure | ||||||
24,944 | 28,939 | 70 | 53,952 | 196 | 54,148 |
- 36 -
For the year ended 31 March | Life Care | Information | Other | Total | Adjustments | Consolidated |
2020 | Technology | |||||
Revenue from external | ||||||
customers | 3,446,191 | 1,807,690 | 43,797 | 5,297,677 | - | 5,297,677 |
Inter-segment sales | 23 | 239 | 10,552 | 10,815 | (10,815) | - |
Total | 3,446,214 | 1,807,929 | 54,349 | 5,308,492 | (10,815) | 5,297,677 |
Interest income | 4,859 | |||||
8,678 | 102 | 13,639 | 18,076 | 31,715 | ||
Interest expense | (12,344) | (3,874) | (12) | (16,231) | 10,605 | (5,625) |
Depreciation and amortisation | (219,107) | (87,738) | (4,535) | (311,380) | (4,468) | (315,848) |
Share of profit (loss) of | ||||||
associates | 638 | 155 | - | 793 | (15,975) | (15,182) |
Impairment losses | (6) | (2,754) | - | (2,760) | - | (2,760) |
Others | (2,648,440) | (912,559) | (49,606) | (3,610,605) | (26,179) | (3,636,784) |
Segment profit before tax | 571,814 | 809,837 | 297 | 1,381,948 | (28,755) | 1,353,192 |
Other disclosure | ||||||
Capital expenditure | ||||||
229,197 | 265,906 | 645 | 495,748 | 1,801 | 497,549 |
Note:
Adjustments to segment profit before tax of (3,129) million yen ((28,755) thousand U.S. dollars) for the year ended 31 March 2020 consist of elimination of inter-segment transactions of 1 million yen (9 thousand U.S. dollars), and profit or loss of the Company's headquarters, the R&D department and overseas holding companies (after elimination of dividend income from Group companies) of (3,130) million yen ((28,765) thousand U.S. dollars).
- 37 -
(3) Revenue from major products and services
The following is an analysis of the Group's revenue from continuing operations from its major products and services for the years ended 31 March 2019 and 2020:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |||
(Note 2)) | |||||
For the year ended | For the year ended | For the year ended | |||
31 March 2019 | 31 March 2020 | 31 March 2020 | |||
Life Care | |||||
Health Care related products | 281,613 | 277,798 | 2,552,586 | ||
Medical related products | 91,775 | 97,251 | 893,605 | ||
Life Care total | 373,388 | 375,049 | 3,446,191 | ||
Information Technology | |||||
Electronics related products | 146,623 | 162,655 | 1,494,580 | ||
Imaging related products | 40,924 | 34,076 | 313,109 | ||
Information Technology total | 187,546 | 196,731 | 1,807,690 | ||
Other | 4,875 | 4,766 | 43,797 | ||
Corporate (R&D) | - | - | - | ||
Total revenue from external | 565,810 | 576,546 | 5,297,677 | ||
customers | |||||
- Information about geographical areas Revenue from external customers
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |||
(Note 2)) | |||||
For the year ended | For the year ended | For the year ended | |||
31 March 2019 | 31 March 2020 | 31 March 2020 | |||
Japan | 163,821 | 163,045 | 1,498,158 | ||
U.S.A. | 85,473 | 83,816 | 770,157 | ||
Singapore | 42,473 | 54,656 | 502,214 | ||
China | 46,439 | 44,835 | 411,975 | ||
South Korea | 27,099 | 31,702 | 291,299 | ||
Others | 200,505 | 198,492 | 1,823,874 | ||
Total | 565,810 | 576,546 | 5,297,677 | ||
Note:
Geographical areas are based on the location of the customers.
Non-current assets in China and South Korea are insignificant; therefore, the amount is included in Others.
- 38 -
Non-current assets | ||||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||||
(Note 2)) | ||||||
For the year ended | For the year ended | For the year ended | ||||
31 March 2019 | 31 March 2020 | 31 March 2020 | ||||
U.S.A. | 67,020 | 66,763 | 613,458 | |||
Japan | 26,816 | 36,634 | 336,612 | |||
Thailand | 19,510 | 20,213 | 185,730 | |||
Vietnam | 10,272 | 17,434 | 160,195 | |||
Singapore | 6,844 | 17,210 | 158,134 | |||
Others | 68,465 | 75,971 | 698,072 | |||
Total | 198,926 | 234,224 | 2,152,201 | |||
Note: |
- Geographical areas are based on the physical location of non-current assets.
- Financial instruments, deferred tax assets, and pension plan assets are not included.
Revenue from external customers in Thailand and Vietnam is insignificant; therefore, the amount is included in Others.
(5) Information about major customers
The Group has no revenue from transactions with a single external customer that amounts to 10% or more of revenue of the Group.
- 39 -
6. Property, plant and equipment
The following are the cost, accumulated depreciation, impairment losses and carrying amount of property, plant and equipment:
(Millions of Yen) | |||||||||||||
Cost | Buildings and | Machinery | Tools, | Land | Construction | Right-of-use | Total | ||||||
structures | and carriers | equipment | in progress | assets | |||||||||
and fixtures | |||||||||||||
Balance at 1 April 2018 | 101,448 | 283,897 | 63,872 | 9,576 | 5,955 | - | 464,749 | ||||||
Additions | 1,489 | 2,639 | - | 22,694 | - | 27,759 | |||||||
938 | |||||||||||||
Acquisitions through business | |||||||||||||
combinations | 566 | 439 | 406 | 48 | 382 | - | 1,841 | ||||||
Disposals (i) | (3,037) | (11,147) | (4,238) | (479) | (118) | - | (19,019) | ||||||
Transfer from construction in | |||||||||||||
progress | 1,490 | 8,649 | 1,141 | 0 | (11,280) | - | - | ||||||
Effect of foreign currency | |||||||||||||
exchange differences | 104 | 1,457 | (1,644) | 49 | 87 | - | 54 | ||||||
Others | (92) | (2,097) | 2,289 | 39 | (1,372) | - | (1,232) | ||||||
Balance at 31 March 2019 | 101,418 | 282,687 | 64,465 | 9,233 | 16,348 | - | 474,150 | ||||||
Cumulative effect of | |||||||||||||
accounting change | (780) | (15) | (635) | - | - | 25,903 | 24,473 | ||||||
Restated balance at 1 April | 100,637 | 282,672 | 63,829 | 9,233 | 16,348 | 25,903 | 498,624 | ||||||
2019 | |||||||||||||
Additions | - | ||||||||||||
543 | 1,797 | 2,495 | 42,026 | 5,925 | 52,786 | ||||||||
Acquisitions through business | |||||||||||||
combinations | 33 | - | 16 | - | - | 116 | 165 | ||||||
Disposals (i) | (1,751) | (8,004) | (2,297) | (38) | (301) | (1,019) | (13,410) | ||||||
Transfer from construction in | |||||||||||||
progress | 3,198 | 16,526 | 1,949 | - | (21,673) | - | - | ||||||
Effect of foreign currency | |||||||||||||
exchange differences | (3,112) | (8,844) | (2,415) | (136) | (572) | (1,039) | (16,119) | ||||||
Others | (597) | 79 | 1,009 | (199) | 986 | 200 | 1,478 | ||||||
Balance at 31 March 2020 | 98,951 | 284,225 | 64,586 | 8,860 | 36,815 | 30,087 | 523,524 |
- 40 -
(Millions of Yen) | |||||||||||||
Accumulated depreciation and | Buildings and | Machinery | Tools, | Land | Construction | Right-of-use | Total | ||||||
impairment losses | structures | and carriers | equipment | in progress | assets | ||||||||
and fixtures | |||||||||||||
Balance at 1 April 2018 | (66,738) | (252,152) | (39,339) | (978) | (49) | - | (359,256) | ||||||
Depreciation expense | (12,700) | (4,303) | - | - | - | (20,858) | |||||||
(3,856) | |||||||||||||
Impairment losses (ii) | (51) | (370) | (360) | (128) | (113) | - | (1,023) | ||||||
Disposals (i) | 2,824 | 9,910 | 4,058 | 3 | 0 | - | 16,795 | ||||||
Effect of foreign currency | |||||||||||||
exchange differences | 122 | (1,600) | 1,518 | - | (1) | - | 38 | ||||||
Others | (267) | 2,516 | (1,045) | 21 | 4 | - | 1,229 | ||||||
Balance at 31 March 2019 | (67,966) | (254,395) | (39,472) | (1,082) | (159) | - | (363,074) | ||||||
Cumulative effect of | |||||||||||||
accounting change | 416 | 10 | 346 | - | - | (772) | - | ||||||
Restated balance at 1 April | |||||||||||||
2019 | (67,551) | (254,385) | (39,125) | (1,082) | (159) | (772) | (363,074) | ||||||
Depreciation expense | - | ||||||||||||
(3,776) | (13,869) | (4,025) | 0 | (7,028) | (28,697) | ||||||||
Impairment losses (ii) | (61) | (223) | (16) | - | - | - | (300) | ||||||
Disposals (i) | 584 | 7,382 | 2,072 | 35 | - | 523 | 10,596 | ||||||
Effect of foreign currency | |||||||||||||
exchange differences | 2,006 | 7,480 | 1,428 | 0 | 1 | 269 | 11,183 | ||||||
Others | 324 | (151) | (871) | (35) | 115 | (311) | (930) | ||||||
Balance at 31 March 2020 | (68,473) | (253,767) | (40,537) | (1,082) | (43) | (7,320) | (371,222) | ||||||
(Millions of Yen) | |||||||||||||
Carrying amount | Buildings and | Machinery | Tools, | Land | Construction | Right-of-use | Total | ||||||
structures | and carriers | equipment | in progress | assets | |||||||||
and fixtures | |||||||||||||
Balance at 1 April 2018 | 34,710 | 31,745 | 24,533 | 8,598 | 5,907 | - | 105,493 | ||||||
Balance at 31 March 2019 | 33,451 | 28,292 | 24,993 | 8,151 | 16,189 | - | 111,077 | ||||||
Balance at 31 March 2020 | 30,478 | 30,458 | 24,049 | 7,778 | 36,772 | 22,767 | 152,302 |
- 41 -
(Thousands of U.S. Dollars (Note 2)) | |||||||||||||
Cost | Buildings and | Machinery | Tools, | Land | Construction | Right-of-use | Total | ||||||
structures | and carriers | equipment | in progress | assets | |||||||||
and fixtures | |||||||||||||
Balance at 31 March 2019 | 931,890 | 2,597,510 | 592,342 | 84,841 | 150,216 | - | 4,356,799 | ||||||
Cumulative effect of | |||||||||||||
accounting change | (7,169) | (135) | (5,837) | - | - | 238,016 | 224,875 | ||||||
Restated balance at 1 April | |||||||||||||
2019 | 924,721 | 2,597,375 | 586,505 | 84,841 | 150,216 | 238,016 | 4,581,674 | ||||||
Additions | 16,513 | 22,926 | - | 386,166 | 54,445 | 485,036 | |||||||
4,986 | |||||||||||||
Acquisitions through business | |||||||||||||
combinations | 300 | - | 148 | - | - | 1,065 | 1,513 | ||||||
Disposals (i) | (16,088) | (73,550) | (21,109) | (346) | (2,761) | (9,361) | (123,216) | ||||||
Transfer from construction in | |||||||||||||
progress | 29,384 | 151,848 | 17,910 | - | (199,142) | - | - | ||||||
Effect of foreign currency | |||||||||||||
exchange differences | (28,593) | (81,268) | (22,195) | (1,253) | (5,254) | (9,547) | (148,110) | ||||||
Others | (5,482) | 721 | 9,272 | (1,829) | 9,058 | 1,838 | 13,579 | ||||||
Balance at 31 March 2020 | 909,227 | 2,611,640 | 593,456 | 81,413 | 338,283 | 276,457 | 4,810,476 | ||||||
(Thousands of U.S. Dollars (Note 2)) | |||||||||||||
Accumulated depreciation and | Buildings and | Machinery | Tools, | Land | Construction | Right-of-use | Total | ||||||
impairment losses | structures | and carriers | equipment | in progress | assets | ||||||||
and fixtures | |||||||||||||
Balance at 31 March 2019 | (624,519) | (2,337,546) | (362,692) | (9,940) | (1,458) | - | (3,336,156) | ||||||
Cumulative effect of | |||||||||||||
accounting change | 3,822 | 91 | 3,183 | - | - | (7,095) | - | ||||||
Restated balance at 1 April | |||||||||||||
2019 | (620,698) | (2,337,455) | (359,509) | (9,940) | (1,458) | (7,095) | (3,336,156) | ||||||
Depreciation expense | (36,980) | - | |||||||||||
(34,698) | (127,433) | (1) | (64,578) | (263,691) | |||||||||
Impairment losses (ii) | (557) | (2,053) | (150) | - | - | - | (2,760) | ||||||
Disposals (i) | 5,370 | 67,827 | 19,042 | 320 | - | 4,804 | 97,363 | ||||||
Effect of foreign currency | |||||||||||||
exchange differences | 18,429 | 68,732 | 13,118 | (1) | 6 | 2,469 | 102,753 | ||||||
Others | 2,975 | (1,390) | (7,999) | (320) | 1,054 | (2,857) | (8,537) | ||||||
Balance at 31 March 2020 | (629,178) | (2,331,772) | (372,479) | (9,942) | (400) | (67,258) | (3,411,028) | ||||||
(Thousands of U.S. Dollars (Note 2)) | |||||||||||||
Carrying amount | Buildings and | Machinery | Tools, | Land | Construction | Right-of-use | Total | ||||||
structures | and carriers | equipment | in progress | assets | |||||||||
and fixtures | |||||||||||||
Balance at 31 March 2020 | 280,049 | 279,868 | 220,977 | 71,471 | 337,883 | 209,200 | 1,399,448 |
Note:
- Gain and loss arising from the sale or disposal of property, plant and equipment for the years ended 31 March 2019 and 2020, are set out in Note 24 "Revenue and expenses (excluding finance income and costs)". Gain and loss on sale of assets held for sale are included in 'gain on sale of property, plant and equipment' and 'loss on sale of property, plant and equipment' in Note 24.
- Details of impairment losses are set out in Note 9 "Impairment losses".
- Property, plant and equipment under construction are included in "construction in progress" in the table above.
- 42 -
Details of commitments for the acquisition of property, plant and equipment are set out in Note 33 "Commitments for expenditure". There is no borrowing cost capitalised and included in the cost of acquisition of property, plant and equipment.
The following are carrying amounts for property, plant and equipment under Right-of-use assets as at 31 March 2020( Lease assets of finance lease as at 31 March 2019, which were included in each corresponding amount) in the preceding table:
(Millions of Yen) | ||||||||
Lease assets of finance lease | Buildings and structures Machinery and carriers | Tools, equipment and | Total | |||||
fixtures | ||||||||
Balance at 31 March 2019 | - | 5 | 289 | 294 | ||||
(Millions of Yen) | ||||||||
Right-of-use assets | Buildings and | Machinery and | Tools, | |||||
equipment and | Land | Others | Total | |||||
structures | carriers | fixtures | ||||||
Balance at 1 April 2019 | 19,238 | 1,008 | 1,006 | 3,869 | 10 | 25,131 | ||
Balance at 31 March 2020 | 17,244 | 947 | 918 | 3,654 | 5 | 22,767 | ||
(Thousands of U.S. Dollars (Note 2)) | ||||||||
Right-of-use assets | Buildings and | Machinery and | Tools, | |||||
equipment and | Land | Others | Total | |||||
structures | carriers | fixtures | ||||||
Balance at 1 April 2019 | 176,771 | 9,263 | 9,246 | 35,548 | 94 | 230,921 | ||
Balance at 31 March 2020 | 158,450 | 8,700 | 8,434 | 33,571 | 44 | 209,200 | ||
- 43 -
7. Leases
(Lessee)
As a lessee, the Group leases buildings mainly for offices and stores. Certain lease contracts include renewals or options and escalation clauses (clauses that increase the lease contract amount). There are no restrictions imposed by lease contracts (such as restrictions on dividends, additional borrowings and additional leases).
The fiscal year ended 31 March 2019 | |||
① Finance lease obligations | |||
Details of finance lease obligations are as follows: | |||
(Millions of Yen) | |||
Minimum lease payments | Present value of minimum | ||
lease payments | |||
As at 31 March 2019 | As at 31 March 2019 | ||
Amounts payable under finance leases: | |||
Not later than one year | 312 | 285 | |
Later than one year but not later than five years | 596 | 577 | |
Total | 908 | 862 | |
Less future finance charges | (46) | ||
Present value of lease obligations | 862 | 862 | |
Less amount due for settlement within 12 months | 285 | ||
Amount due for settlement after 12 months | 577 | ||
The Group has not entered into any new finance lease contracts as part of its policy, except for cases when it concludes that it has a number of advantages of having a lease arrangement in respect of cost reduction or the avoidance of the risk associated with product obsolescence. The average remaining lease term is approximately two to four years as at 31 March 2019.
②Operating lease arrangements
Details of minimum lease payments and contingent lease payments for the period under operating lease arrangements are as follows: (Millions of Yen)
For the year ended 31 March 2019
Minimum lease payments Contingent rent
Total
The amounts above are included in the line item 'Other expenses' in the consolidated statement of comprehensive income. Contingent rent, which is determined in rent contracts for stores at shopping malls, is the rent based on the stores' sales amounts.
As at 31 March 2019, the maturity periods of the outstanding commitments under non-cancellable operating leases are as follows: (Millions of Yen)
As at 31 March 2019 | |
Not later than one year | |
1,770 | |
Later than one year but not later than five years | 4,225 |
Later than five years | 763 |
Total | 6,758 |
Operating lease payments represent rentals payable by the Group for the land used for offices, buildings, etc. The average remaining operating lease terms for those assets as at 31 March 2019, are 26 years and four years, respectively.
- 44 -
The fiscal year ended 31 March 2020 | ||
Details of expenses relating to leases are as follows: | ||
(Millions of Yen) | (Thousands of U.S. Dollars (Note 2)) | |
For the year ended 31 March 2020 | For the year ended 31 March 2020 | |
Depreciation of right-of-use assets | ||
Buildings and structures | 5,967 | 54,830 |
Machinery and carriers | 564 | 5,184 |
Tools, equipment and fixtures | 354 | 3,249 |
Land | 134 | 1,233 |
Software | 9 | 82 |
Total | 7,028 | 64,578 |
Interest expense on lease liabilities | 407 | 3,740 |
Expense relating to short-term leases | 1,548 | 14,225 |
Expense relating to leases of low-value assets | 461 | 4,238 |
Expense relating to variable lease payments (Note) | 1,190 | 10,935 |
(Note) The expense is not included in the measurement of lease liabilities.
Expense relating to variable lease payments is linked with sales revenue stipulated in the lease contracts of the store operated in shopping center, etc.
Depreciation of right-of-use assets is included in the line item 'Depreciation and amortisation', interest expense on lease liabilities is in 'Finance costs' and expenses relating to short-term leases, leases of low-value assets and variable lease payments are in 'Other expenses' in the consolidated statement of comprehensive income.
For the year ended 31 March 2020, total cash outflow for leases is 10,746 million yen (98,745 thousand U.S. dollars). A maturity analysis of lease liabilities is set out in Note 21 "Financial instruments"
- 45 -
(Lessor) | |||
① Finance leases | |||
The Group leases its products and merchandises as a lessor. | |||
Profit from finance lease contracts is as follows: | |||
(Millions of Yen) | (Thousands of U.S. Dollars (Note | ||
2)) | |||
For the year ended 31 March 2020 | For the year ended 31 March 2020 | ||
Finance income on the net investment in the lease | 45 | 415 | |
A maturity analysis of the receivable under finance lease contracts is as follows: | |||
(Millions of Yen) | (Thousands of U.S. Dollars (Note | ||
2)) | |||
As at 31 March 2020 | As at 31 March 2020 | ||
Not later than one year | 371 | 3,405 | |
Later than one year but not later than two years | 319 | 2,933 | |
Later than two years but not later than three years | 223 | 2,046 | |
Later than three years but not later than four years | 146 | 1,339 | |
Later than four years but not later than five years | 70 | 648 | |
Later than five years | 95 | 874 | |
Total | 1,224 | 11,245 | |
Unearned finance income | (66) | (605) | |
Net investment on the lease | 1,158 | 10,641 | |
- 46 -
8. Goodwill and intangible assets
The following are the cost, accumulated amortisation, impairment losses and carrying amount of goodwill and intangible assets:
(Millions of Yen)
Cost | Goodwill | Intangible assets | ||||
Software | Technology | Customer | Others (i) | Total | ||
related assets | ||||||
Balance at 1 April 2018 | 40,596 | 21,918 | 15,316 | 27,765 | 6,847 | 71,846 |
Additions | - | 1,394 | - | - | 51 | 1,445 |
Acquisitions through business | ||||||
combinations | 9,628 | 1 | 5,498 | 4,939 | 456 | 10,893 |
Disposals | - | (1,090) | - | - | (10) | (1,100) |
Effect of foreign currency | ||||||
exchange differences | 659 | 43 | 526 | (43) | 51 | 577 |
Others | 253 | 77 | - | (773) | 68 | (629) |
Balance at 31 March 2019 | 51,136 | 22,342 | 21,339 | 31,887 | 7,462 | 83,031 |
Additions | - | 1,288 | 4 | - | 70 | 1,362 |
Acquisitions through business | ||||||
combinations | 28 | - | - | 1,473 | - | 1,473 |
Disposals | - | (341) | (15) | (27) | (3) | (386) |
Effect of foreign currency | ||||||
exchange differences | (1,676) | (607) | (530) | (2,826) | (1,130) | (5,093) |
Others | (58) | 510 | (37) | (107) | 15 | 381 |
Balance at 31 March 2020 | 49,430 | 23,193 | 20,762 | 30,400 | 6,413 | 80,767 |
(Millions of Yen) | ||||||
Accumulated amortisation and | Goodwill | Intangible assets | ||||
impairment losses | Software | Technology | Customer | Others | Total | |
related assets | ||||||
Balance at 1 April 2018 | (8,704) | (17,647) | (4,390) | (8,791) | (4,155) | (34,983) |
Amortisation expense (ii) | - | (1,246) | (1,276) | (2,521) | (514) | (5,558) |
Impairment loss (iii) | - | (76) | - | - | - | (76) |
Disposals | - | 1,016 | - | - | - | 1,016 |
Effect of foreign currency | ||||||
exchange differences | 380 | (23) | (153) | 206 | (83) | (52) |
Others | 32 | 81 | - | 857 | (8) | 930 |
Balance at 31 March 2019 | (8,293) | (17,896) | (5,818) | (10,249) | (4,760) | (38,723) |
Amortisation expense (ii) | - | (1,136) | (1,575) | (2,460) | (504) | (5,676) |
Impairment loss (iii) | - | - | - | - | - | - |
Disposals | - | 335 | - | - | 1 | 335 |
Effect of foreign currency | ||||||
exchange differences | 909 | 459 | 141 | 1,880 | 1,008 | 3,488 |
Others | 35 | (448) | 59 | 18 | (23) | (395) |
Balance at 31 March 2020 | (7,348) | (18,687) | (7,194) | (10,811) | (4,280) | (40,971) |
- 47 -
(Millions of Yen) | ||||||
Carrying amount | Goodwill | Intangible assets | ||||
Software | Technology | Customer | Others | Total | ||
related assets | ||||||
Balance at 1 April 2018 | 31,892 | 4,270 | 10,926 | 18,974 | 2,693 | 36,863 |
Balance at 31 March 2019 | 42,843 | 4,446 | 15,521 | 21,639 | 2,702 | 44,308 |
Balance at 31 March 2020 | 42,082 | 4,506 | 13,567 | 19,589 | 2,133 | 39,796 |
(Thousands of U.S. Dollars (Note 2)) | ||||||
Cost | Goodwill | Intangible assets | ||||
Software | Technology | Customer | Others (i) | Total | ||
related assets | ||||||
Balance at 31 March 2019 | 469,869 | 205,296 | 196,079 | 293,002 | 68,564 | 762,942 |
Additions | - | 11,832 | 41 | - | 640 | 12,513 |
Acquisitions through business | ||||||
combinations | 258 | - | - | 13,533 | - | 13,533 |
Disposals | - | (3,133) | (137) | (250) | (29) | (3,550) |
Effect of foreign currency | ||||||
exchange differences | (15,397) | (5,573) | (4,870) | (25,968) | (10,387) | (46,798) |
Others | (536) | 4,687 | (343) | (985) | 138 | 3,497 |
Balance at 31 March 2020 | 454,194 | 213,109 | 190,770 | 279,332 | 58,925 | 742,137 |
(Thousands of U.S. Dollars (Note 2)) | ||||||
Accumulated amortisation and | Goodwill | Intangible assets | ||||
impairment losses | Software | Technology | Customer | Others | Total | |
related assets | ||||||
Balance at 31 March 2019 | (76,198) | (164,444) | (53,463) | (94,172) | (43,737) | (355,816) |
Amortisation expense (ii) | - | (10,441) | (14,474) | (22,606) | (4,635) | (52,157) |
Impairment loss (iii) | - | - | - | - | - | - |
Disposals | - | 3,076 | - | - | 6 | 3,083 |
Effect of foreign currency | ||||||
exchange differences | 8,356 | 4,219 | 1,292 | 17,277 | 9,259 | 32,047 |
Others | 324 | (4,115) | 540 | 164 | (216) | (3,627) |
Balance at 31 March 2020 | (67,518) | (171,705) | (66,105) | (99,337) | (39,323) | (376,470) |
- 48 -
(Thousands of U.S. Dollars (Note 2)) | ||||||
Carrying amount | Goodwill | Intangible assets | ||||
Software | Technology | Customer | Others | Total | ||
related assets | ||||||
Balance at 31 March 2020 | 386,677 | 41,405 | 124,665 | 179,996 | 19,602 | 365,667 |
Note:
- There were no significant internally generated intangible assets for the years ended 31 March 2019 and 2020.
- Amortisation expense is included in the line item 'Depreciation and amortisation' in the consolidated statement of comprehensive income.
- Refer to Note 9 "Impairment losses" for details of impairment losses.
No intangible assets have been pledged as collateral to secure the debt. There is no restriction on legal title of these assets. Details of commitments for the acquisition of intangible assets are set out in Note 33 "Commitments for expenditure".
Details of intangible assets in the consolidated statement of financial position are as follows:
As at 31 March 2019 | As at 31 March 2020 | |||
Carrying amount | ||||
Carrying amount | Remaining useful | Carrying amount | (Thousands of | Remaining useful |
(Millions of Yen) | lives (Years) | (Millions of Yen) | U.S. Dollars | lives (Years) |
(Note 2)) |
Health Care related | ||||||
Technology | products | 1,997 | 9 | 1,683 | 15,461 | 8 |
Medical related | ||||||
products | 13,353 | 10 | 11,772 | 108,166 | 9 | |
Health Care related | ||||||
Customer related | products | 13,676 | 11 | 12,368 | 113,647 | 10 |
assets | Medical related | |||||
products | 6,088 | 13 | 5,292 | 48,622 | 12 | |
- 49 -
9. Impairment losses
The following are the details of impairment losses recognised.
Impairment losses have been included in the line item 'Impairment losses' in the consolidated statement of comprehensive income.
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars (Note 2)) | |
For the year ended 31 March 2019 | For the year ended 31 March 2020 | For the year ended 31 March 2020 | |
Buildings and structures | 51 | 61 | 557 |
Machinery and equipment | 370 | 223 | 2,053 |
Tools, equipment and fixtures | 360 | 16 | 150 |
Land | 128 | - | - |
Construction in progress | 113 | - | - |
Total impairment losses on | |||
property, plant and equipment | 1,023 | 300 | 2,760 |
Software | 76 | - | - |
Total impairment losses on | |||
intangible assets | 76 | - | - |
Total impairment losses | 1,099 | 300 | 2,760 |
(1) Cash-generating units
The Group identifies each strategic business unit ("SBU") as a cash-generating unit for impairment testing purposes. Each business unit has been set based on the production and sale of product lines. For any asset expected to be sold or disposed, or any idle asset, the asset is individually tested for impairment.
-
Impairment losses on assets in business units For the year ended 31 March 2019
No impairment losses on assets were recognised in business units.
For the year ended 31 March 2020
No impairment losses on assets were recognised in business units.
- 50 -
(3) Impairment losses on idle assets
For the year ended 31 March 2019, the carrying amount of the related assets, which were not expected to be used in the future due to business restructuring, was written down to the recoverable amount which was measured at fair value less related selling costs, and the corresponding impairment loss was recognised.
Impairment losses were recognised as follows for the year ended 31 March 2019:
(Millions of Yen) | ||
Impairment losses | ||
Life Care | ||
Buildings and structures | 35 | |
Machinery and carriers | 105 | |
Tools, equipment and fixtures | 360 | |
Construction in progress | 113 | |
Software | 76 | |
Total Life Care | 690 | |
Information Technology | ||
Buildings and structures | 16 | |
Machinery and carriers | 265 | |
Total Information Technology | 281 | |
Corporate | ||
Land | 128 | |
Total Corporate | 128 | |
Total | 1,099 | |
For the year ended 31 March 2020, the carrying amount of the related assets, which were not expected to be used in the future due to business restructuring, was written down to the recoverable amount which was measured at fair value less related selling costs, and the corresponding impairment loss was recognised.
Impairment losses were recognised as follows for the year ended 31 March 2020:
(Millions of Yen) | (Thousands of U.S. Dollars (Note 2)) | |||
Impairment losses | Impairment losses | |||
Life Care | ||||
Tools, equipment and fixtures | 1 | 6 | ||
Total Life Care | 1 | 6 | ||
Information Technology | ||||
Buildings and structures | 61 | 557 | ||
Machinery and carriers | 223 | 2,053 | ||
Tools, equipment and fixtures | 16 | 144 | ||
Total Information Technology | 300 | 2,754 | ||
Total | 300 | 2,760 | ||
- 51 -
Life Care | Other | |||||
Health Care related | Medical related products | Other | Total | |||
products | ||||||
Eyeglass lenses | Medical accessories | |||||
- | 1,524 | |||||
791 | 733 | |||||
26,303 | 12,824 | - | 39,128 | |||
623 | 801 | 525 | 1,950 | |||
242 | - | - | 242 | |||
27,960 | 14,358 | 525 | 42,843 | |||
(Millions of Yen) | ||||||
As at 31 March 2020 | ||||||
Life Care | Other | |||||
Health Care related | Medical related products | Other | Total | |||
products | ||||||
Eyeglass lenses | Medical accessories | |||||
849 | 733 | - | 1,582 | |||
25,444 | 12,981 | - | 38,425 | |||
551 | 769 | 504 | 1,823 | |||
252 | - | - | 252 | |||
27,096 | 14,482 | 504 | 42,082 | |||
(Thousands of U.S. Dollars (Note 2)) | ||||||
As at 31 March 2020 | ||||||
Life Care | Other | |||||
Health Care related | Medical related products | Other | Total | |||
products | ||||||
Eyeglass lenses | Medical accessories | |||||
- | 14,536 | |||||
7,803 | 6,733 | |||||
233,796 | 119,278 | - | 353,074 | |||
5,059 | 7,061 | 4,633 | 16,753 | |||
2,314 | - | - | 2,314 | |||
248,972 | 133,072 | 4,633 | 386,677 |
- 52 -
10. Investments in associates
A summary of the Group's associates, which are not individually significant, is as follows: | |||||||||||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |||||||||||
Dollars (Note 2)) | |||||||||||||
As at / for the year | As at / for the year | As at / for the year | |||||||||||
ended 31 March 2019 | ended 31 March 2020 | ended 31 March 2020 | |||||||||||
The Group's share of net income (loss) | (1,113) | (1,652) | (15,182) | ||||||||||
The Group's share of other comprehensive income (loss) | (16) | 76 | 701 | ||||||||||
The Group's share of comprehensive income (loss) | (1,129) | (1,576) | (14,481) | ||||||||||
The Group's share of net assets | 349 | 1,007 | 9,250 | ||||||||||
Details of the Group's major associates, which are not individually significant, are as follows: | |||||||||||||
Place of | Ownership interest (%) | ||||||||||||
Name of associate | Principal activity | incorporation and | Segment | As at | As at | ||||||||
operation | 31 March 2019 | 31 March 2020 | |||||||||||
AVANSTRATE, INC. | Production and | JAPAN | Corporate | 46.6 | 46.6 | ||||||||
sale of glass | |||||||||||||
substrate for thin | |||||||||||||
film transistor | |||||||||||||
(TFT) liquid | |||||||||||||
crystal | |||||||||||||
EYE-Q VISION PRIVATE | Medical services | INDIA | Corporate | 24.3 | 24.3 | ||||||||
LIMITED | related to | ||||||||||||
ophthalmology | |||||||||||||
HTK LENTES OFTALMICAS | Sale of optical | BRAZIL | Life Care | 37.6 | 37.6 | ||||||||
LTDA | lens | ||||||||||||
JIASHAN CANDEO OPTICAL | Production and | CHINA | Information | 49.0 | 49.0 | ||||||||
GLASS CO., LTD. | sale of special | Technology | |||||||||||
glass, such as | |||||||||||||
coloured glass | |||||||||||||
The Group's unrecognised share of loss on associates is as follows: | |||||||||||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |||||||||||
Dollars (Note 2)) | |||||||||||||
As at / for the year | As at / for the year | As at / for the year | |||||||||||
ended 31 March 2019 | ended 31 March 2020 | ended 31 March 2020 | |||||||||||
The Group's unrecognised share of net loss | 608 | 6,392 | 58,736 | ||||||||||
The Group's unrecognised share of accumulated net loss | 8,002 | 14,394 | 132,262 | ||||||||||
- 53 -
11. Deferred taxes and income taxes
(1) Deferred taxes | ||||||
Details of deferred tax assets and liabilities are as follows: | ||||||
(Millions of Yen) | ||||||
Recognised | ||||||
As at | Recognised in | in other | Business | As at | ||
1 April 2018 | profit or loss | comprehensive | combinations | 31 March 2019 | ||
income | ||||||
Temporary differences | ||||||
Enterprise tax payable | 573 | (221) | - | - | 353 | |
Write-down of inventories | 1,033 | 345 | - | 132 | 1,511 | |
Allowance for doubtful | 588 | 149 | - | - | 737 | |
accounts | ||||||
Provisions | 805 | 12 | - | - | 817 | |
Accrued expenses | 3,665 | 566 | - | 274 | 4,504 | |
Unrealised profit on inventories | 2,521 | 666 | - | - | 3,187 | |
Depreciation and amortisation | 1,349 | 88 | - | - | 1,437 | |
Impairment losses | 546 | 202 | - | - | 748 | |
Exchange differences on | 3 | - | 124 | - | 127 | |
translating foreign operations | ||||||
Others | 3,184 | (1,584) | (10) | - | 1,590 | |
Subtotal | 14,267 | 223 | 114 | 406 | 15,010 | |
Undistributed retained earnings | (2,192) | (861) | - | - | (3,053) | |
of subsidiaries | ||||||
Depreciation and amortisation | (6,154) | 767 | - | (3,001) | (8,389) | |
Financial assets measured at | (164) | - | (135) | - | (300) | |
fair value through other | ||||||
comprehensive income | ||||||
Others | (421) | (23) | - | - | (444) | |
Subtotal | (8,932) | (117) | (135) | (3,001) | (12,185) | |
Tax loss carryforwards and tax | ||||||
credits | ||||||
Tax loss carryforwards | 2,716 | (324) | - | - | 2,392 | |
Tax credits | 8 | 21 | - | - | 29 | |
Subtotal | 2,724 | (303) | - | - | 2,421 | |
Total | ||||||
8,059 | (197) | (21) | (2,595) | 5,246 | ||
Note:
The difference between the total amount of "Recognised in profit or loss" as above and "Deferred tax expenses" in Note 11 "Deferred tax and income taxes" (2) Income taxes is due to foreign exchange fluctuations.
- 54 -
(Millions of Yen) | ||||||
Cumulative | As at | Recognised | ||||
As at | effect of | Recognised in | in other | As at | ||
1 April 2019 | ||||||
1 April 2019 | accounting | profit or loss | comprehensive | 31 March 2020 | ||
(Restated) | ||||||
change | income | |||||
Temporary differences | ||||||
Enterprise tax payable | 353 | - | 353 | 340 | - | 693 |
Write-down of inventories | 1,511 | - | 1,511 | (61) | - | 1,450 |
Allowance for doubtful | 737 | - | 737 | (326) | - | 411 |
accounts | ||||||
Provisions | 817 | - | 817 | 330 | - | 1,147 |
Accrued expenses | 4,504 | - | 4,504 | (929) | - | 3,575 |
Unrealised profit on inventories | 3,187 | - | 3,187 | (300) | - | 2,887 |
Depreciation and amortisation | 1,437 | - | 1,437 | 690 | - | 2,126 |
Impairment losses | 748 | - | 748 | (156) | - | 592 |
Exchange differences on | 127 | - | 127 | 75 | (203) | - |
translating foreign operations | ||||||
Lease obligations | - | 2,772 | 2,772 | - | - | 2,772 |
Others | 1,590 | - | 1,590 | 951 | 22 | 2,563 |
Subtotal | 15,010 | 2,772 | 17,783 | 615 | (181) | 18,216 |
Undistributed retained earnings | (3,053) | - | (3,053) | (799) | - | (3,852) |
of subsidiaries | ||||||
Depreciation and amortisation | (8,389) | - | (8,389) | 70 | - | (8,319) |
Lease obligations | (2,948) | (2,948) | - | - | (2,948) | |
Financial assets measured at | (300) | - | (300) | 299 | (234) | (234) |
fair value through other | ||||||
comprehensive income | ||||||
Others | (444) | - | (444) | (242) | - | (686) |
Subtotal | (12,185) | (2,948) | (15,134) | (672) | (234) | (16,040) |
Tax loss carryforwards and tax | ||||||
credits | ||||||
Tax loss carryforwards | 2,392 | - | 2,392 | (477) | - | 1,915 |
Tax credits | 29 | - | 29 | 18 | - | 47 |
Subtotal | 2,421 | - | 2,421 | (459) | - | 1,962 |
Total | ||||||
5,246 | (176) | 5,070 | (516) | (415) | 4,139 |
Note:
The difference between the total amount of "Recognised in profit or loss" as above and "Deferred tax expenses" in Note 11 "Deferred taxes and income taxes" (2) Income taxes is due to foreign exchange fluctuations.
- 55 -
(Thousands of U.S. Dollars (Note 2)) | |||||||
Cumulative | As at | Recognised | |||||
As at | effect of | Recognised in | in other | As at | |||
1 April 2019 | |||||||
1 April 2019 | accounting | profit or loss | comprehensive | 31 March 2020 | |||
(Restated) | |||||||
change | income | ||||||
Temporary differences | |||||||
Enterprise tax payable | 3,240 | - | 3,240 | 3,123 | - | 6,363 | |
Write-down of inventories | 13,882 | - | 13,882 | (558) | - | 13,324 | |
Allowance for doubtful | 6,771 | - | 6,771 | (2,996) | - | 3,775 | |
accounts | |||||||
Provisions | 7,508 | - | 7,508 | 3,031 | - | 10,538 | |
Accrued expenses | 41,389 | - | 41,389 | (8,536) | - | 32,853 | |
Unrealised profit on inventories | 29,283 | - | 29,283 | (2,754) | - | 26,529 | |
Depreciation and amortisation | 13,200 | - | 13,200 | 6,338 | - | 19,538 | |
Impairment losses | 6,873 | - | 6,873 | (1,430) | - | 5,443 | |
Exchange differences on | 1,170 | - | 1,170 | 693 | (1,863) | - | |
translating foreign operations | |||||||
Lease obligations | - | 25,475 | 25,475 | - | - | 25,475 | |
Others | 14,611 | - | 14,611 | 8,736 | 200 | 23,546 | |
Subtotal | 137,926 | 25,475 | 163,401 | 5,647 | (1,663) | 167,385 | |
Undistributed retained earnings | (28,053) | - | (28,053) | (7,342) | - | (35,395) | |
of subsidiaries | |||||||
Depreciation and amortisation | (77,082) | - | (77,082) | 643 | - | (76,439) | |
Financial assets measured at | (2,752) | - | (2,752) | 2,749 | (2,149) | (2,153) | |
fair value through other | |||||||
comprehensive income | |||||||
Lease obligations | - | (27,090) | (27,090) | - | - | (27,090) | |
Others | (4,080) | - | (4,080) | (2,228) | - | (6,308) | |
Subtotal | (111,967) | (27,090) | (139,056) | (6,178) | (2,149) | (147,383) | |
Tax loss carryforwards and tax | |||||||
credits | |||||||
Tax loss carryforwards | 21,978 | - | 21,978 | (4,383) | - | 17,595 | |
Tax credits | 264 | - | 264 | 169 | - | 432 | |
Subtotal | 22,242 | - | 22,242 | (4,214) | - | 18,027 | |
Total | |||||||
48,201 | (1,615) | 46,586 | (4,745) | (3,812) | 38,029 | ||
Note:
The difference between the total amount of "Recognised in profit or loss" as above and "Deferred tax expenses" in Note 11 "Deferred taxes and income taxes" (2) Income taxes is due to foreign exchange fluctuations.
- 56 -
Tax loss carryforwards and deductible temporary differences for which deferred tax assets have not been recognised are as follows:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |
Dollars (Note 2)) | |||
As at | As at | As at | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Tax loss carryforwards | 13,130 | 11,120 | 102,179 |
Deductible temporary differences | 4,128 | 4,226 | 38,829 |
Total | 17,258 | 15,346 | 141,008 |
The expiration date and amounts of tax loss carryforwards for which deferred tax assets are not recognised are as follows: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |
Dollars Note 2)) | |||
As at | As at | As at | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Year 1 | 1,890 | 1,329 | 12,216 |
Year 2 | 1,750 | 611 | 5,614 |
Year 3 | 1,134 | 820 | 7,535 |
Year 4 | 513 | 403 | 3,706 |
Year 5 or later | 7,843 | 7,956 | 73,107 |
Total | 13,130 | 11,120 | 102,177 |
The aggregate amounts of temporary differences associated with undistributed retained earnings of the subsidiaries for which deferred tax liabilities have not been recognised at 31 March 2019 and 2020, were 322,017 million yen and 327,573 million yen (3,009,954 thousand U.S. dollars), respectively. No liability has been recognised in respect of these differences because the Group is in a position to control the timing of the reversal of the temporary differences and it is probable that such differences will not reverse in the foreseeable future.
(2) Income taxes
In Japan, the normal effective statutory tax rates are 30.5% for each of the years ended 31 March 2019 and 2020.
Current or deferred taxes in other tax jurisdictions are calculated by the tax rates generally applied to those tax jurisdictions. Details of current tax expense and deferred tax expense are as follows:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |
Dollars (Note 2)) | |||
For the year ended | For the year ended | For the year ended | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Current tax expense: (i) | |||
Current year | 22,915 | 31,948 | 293,560 |
Prior years | (690) | 454 | 4,169 |
Total current tax expense | 22,225 | 32,402 | 297,729 |
Deferred tax expense: (ii) | |||
Origination and reversal of temporary difference | 318 | 252 | 2,314 |
Changes in tax rates | 41 | 27 | 251 |
Total deferred tax expense | 359 | 279 | 2,566 |
Total income tax expense | 22,584 | 32,681 | 300,295 |
Continuing operations | 22,584 | 32,681 | 300,295 |
Discontinued operations | - | - | - |
Note: |
- "Current tax expense" includes previously unrecognised tax benefits from tax loss carryforwards, tax credits and deductible temporary differences. These benefits were 194 million yen and 15 million yen (142 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.
- 57 -
- "Deferred tax expense" includes previously unrecognised tax benefits from tax loss carryforwards, tax credits, deductible temporary differences, and expenses or benefits arising from write-downs of deferred tax assets or the reversal of previous write- downs of deferred tax assets. These effects increased the deferred tax expense by 471 million yen and 660 million yen (6,061 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.
- On 26 June 2013, the Company received a reassessment notice from the Tokyo Regional Taxation Bureau ("TRTB") for additional tax on the transfer pricing taxation of transactions with overseas subsidiaries that develop and manufacture electronics- related products for the five financial years ended 31 March 2007 to 2011. The Company has lodged an objection with TRTB seeking withdrawal of the assessment in accordance with the relevant law.
On 29 March 2018, the Company received a written verdict from the National Tax Tribunal (the "Tribunal"), which partially cancels the reassessments. The Company disagrees with the remaining findings of the Tribunal's verdict that maintains portions of the reassessment and the Company expects to appeal the findings in court to seek cancellation of all the reassessments by the tax authorities. Consequently, the paid amount of 7,916 million yen (72,740 thousand U.S. dollars) is included in "Other current assets" as a suspense payment.
On 27 June 2018, the Company received a reassessment notice from TRTB for additional taxes on the transfer pricing taxation of transactions with overseas subsidiaries that developed and manufactured electronics-related products for the three financial years ended 31 March 2012, 2013 and 2014. The Company has lodged an objection with TRTB seeking withdrawal of the assessment in accordance with the relevant law. The additional tax assessment of 5,174 million yen (47,544 thousand U.S. dollars) is included in "Other current assets" as a suspense payment.
A reconciliation of the normal effective statutory tax rate with the actual tax rate is as follows. The actual tax rate represents the ratio of income tax expense and profit before tax from continuing operations.
For the year ended | For the year ended | ||
31 March 2019 | 31 March 2020 | ||
Effective statutory tax rate | 30.5% | ||
30.5% | |||
Expenses not deductible for tax purposes | 0.5% | 1.1% | |
Income not taxable for tax purposes | (3.1)% | (0.6)% | |
Effect of unrecognised deferred tax assets | 0.3% | 0.1% | |
Impact of different tax rates applied to overseas subsidiaries | (15.2)% | (12.0)% | |
Profits and losses on investments in associates | 0.2% | 0.1% | |
Adjustment on deferred tax assets and liabilities due to the change of corporate tax | |||
rate | 0.0% | (0.0)% | |
Tax rate difference due to the elimination of unrealised profit on inventories | 0.2% | (0.2)% | |
Increase/decrease in deferred tax liabilities related to undistributed earnings of foreign | |||
subsidiaries | 0.6% | 0.5% | |
Prior year income taxes | (0.5)% | 0.3% | |
Foreign withholding tax arising from dividends from subsidiaries | 1.0% | 0.0% | |
Others | 1.1% | 2.4% | |
Actual tax rate | 15.6% | 22.2% |
There was no effect on income tax resulting from dividends paid to shareholders.
- 58 -
12. Other financial assets and liabilities
(1) Details of other financial assets and liabilities | ||||||||
Details of other financial assets and liabilities are as follows: | ||||||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | ||||||
Dollars (Note 2)) | ||||||||
As at | As at | As at | ||||||
31 March 2019 | 31 March 2020 | 31 March 2020 | ||||||
Other financial assets | ||||||||
Other financial assets measured at amortised cost | 17,370 | 16,490 | 151,518 | |||||
FVTOCI financial assets | 29,863 | 30,789 | 282,906 | |||||
Total | 47,233 | 47,278 | 434,424 | |||||
Total non-current assets (long-term financial | ||||||||
assets) | 44,103 | 45,975 | 422,448 | |||||
Total current assets (other short-term financial | ||||||||
assets) | 3,131 | 1,303 | 11,976 | |||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | ||||||
Dollars (Note 2)) | ||||||||
As at | As at | As at | ||||||
31 March 2019 | 31 March 2020 | 31 March 2020 | ||||||
Other financial liabilities | ||||||||
FVTPL financial liabilities | 3,082 | 542 | 4,976 | |||||
Other financial liabilities measured at amortised | ||||||||
cost | 8,500 | 26,205 | 240,785 | |||||
Total | 11,582 | 26,746 | 245,761 | |||||
Total non-current liabilities (other long-term | ||||||||
financial liabilities) | 10,936 | 23,923 | 219,817 | |||||
Total current liabilities (other short-term financial | ||||||||
liabilities) | 646 | 2,824 | 25,944 | |||||
(2) Details of FVTOCI financial assets | ||||||||
Details of FVTOCI financial assets are as follows: | ||||||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||||||
(Note 2)) | ||||||||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | ||||||
KIOXIA Holdings Corporation | 27,000 | 28,200 | 259,123 | |||||
The asset above is designated as FVTOCI because its profit and loss is not related to the business profit and loss, while there is a possibility of selling it in the future.
- 59 -
(3) Derecognition of FVTOCI financial assets
The Group derecognises FVTOCI financial assets when they are partially sold, considering the capital efficiency, reconsideration of business relationships and so on.
Details of fair value and cumulative gain or loss in other comprehensive income at the time of selling in the year ended 31 March 2019 and 2020 are as follows:
Fair value | Cumulative gain or loss | ||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | (Millions of Yen) | (Millions of Yen) | (Thousands of U.S. |
Dollars (Note 2)) | Dollars (Note 2)) | ||||
For the year ended | For the year ended | For the year ended | For the year ended | For the year ended | For the year ended |
31 March 2019 | 31 March 2020 | 31 March 2020 | 31 March 2019 | 31 March 2020 | 31 March 2020 |
11 | 357 | 3,280 | 6 | 88 | 804 |
Cumulative gain or loss in other comprehensive income is transferred to retained earnings when FVTOCI assets are derecognised. The amount of cumulative other comprehensive income or loss (after deduction of tax) which was transferred to retained earnings were 6 million yen and 61 million yen (559 thousand U.S. dollars) in the year ended 31 March 2019 and 2020.
Details of dividends income recognised from equity instruments are as follows: | |||||||
Derecognised investment | Investment held as at 31 March 2020 | ||||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | (Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | ||
Dollars (Note 2)) | Dollars (Note 2)) | ||||||
For the year ended | For the year ended | For the year ended | For the year ended | For the year ended | For the year ended | ||
31 March 2019 | 31 March 2020 | 31 March 2020 | 31 March 2019 | 31 March 2020 | 31 March 2020 | ||
0 | - | - | 10 | 10 | 92 | ||
13. Other assets and liabilities
Details of other assets and liabilities are as follows: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |
Dollars (Note 2)) | |||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
Non-current: Other assets | |||
Long-term prepaid expenses | 2,187 | 412 | 3,784 |
Others | 773 | 274 | 2,513 |
Total | 2,960 | 685 | 6,297 |
Current: Other assets | |||
Suspense payment (Note) | 13,090 | 13,090 | 120,283 |
Prepaid expenses | 4,131 | 2,368 | 21,762 |
Refundable consumption taxes | 1,406 | 1,457 | 13,383 |
Others | 2,319 | 2,992 | 27,488 |
Total | 20,946 | 19,907 | 182,918 |
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |
Dollars (Note 2)) | |||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
Non-current: Other liabilities | |||
Deposit received and long-term advance | 2,303 | 1,363 | 12,526 |
revenue, etc. | |||
Total | 2,303 | 1,363 | 12,526 |
Current: Other liabilities | |||
Accrued salary/bonus/vacation pay | 16,357 | 15,894 | 146,040 |
Other accrued expenses | 17,793 | 16,504 | 151,653 |
Advance received/deferred revenue | 5,356 | 4,140 | 38,042 |
Accrued consumption taxes | 1,897 | 1,536 | 14,115 |
Others | 2,769 | 2,107 | 19,359 |
Total | 44,171 | 40,181 | 369,209 |
Note:
On 26 June 2013, the Company received a reassessment notice from the Tokyo Regional Taxation Bureau (‟TRTB") for additional tax on the transfer pricing taxation of transactions with overseas subsidiaries that develop and manufacture electronics- related products for the five financial years ended 31 March 2007 to 2011. The Company has lodged an objection with TRTB seeking withdrawal of the assessment in accordance with the relevant law.
On 29 March 2018, the Company received a written verdict from the National Tax Tribunal (the "Tribunal"), which partially cancels the reassessments. The Company disagrees with the remaining findings of the Tribunal's verdict that maintains portions of the reassessment and the Company expects to appeal the findings in court to seek cancellation of all the reassessments by the tax authorities.
Consequently, the paid amount of 7,916 million yen is included in "Other current assets" as a suspense payment.
On 27 June 2018, the Company received a reassessment notice from the TRTB for additional taxes on the transfer pricing taxation of transactions with overseas subsidiaries that developed and manufactured electronics-related products for the three financial years ended 31 March 2012, 2013 and 2014. The Company has lodged an objection with TRTB seeking withdrawal of the assessment in accordance with the relevant law. The additional tax assessment of 5,174 million yen is included in ‟Other current assets" as a suspense payment.
- 61 -
14. Inventories
Details of inventories are as follows: | ||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||
(Note 2)) | ||||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | ||
Goods and products | 40,330 | 39,042 | 358,744 | |
Work in progress | 8,566 | 7,791 | 71,586 | |
Raw materials | 18,953 | 18,506 | 170,048 | |
Supplies | 11,124 | 12,791 | 117,532 | |
Total | 78,973 | 78,130 | 717,910 | |
Inventories expected to be sold | 7 | 4 | 35 | |
after more than 12 months | ||||
The cost of inventories recognised as an expense during the years ended 31 March 2019 and 2020, was 250,891 million yen and 252,630 million yen (2,321,324 thousand U.S. dollars), respectively.
The cost of inventories recognised as an expense in respect of write-down and the reversal of such write-down is as follows:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
For the year ended | For the year ended | For the year ended | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Amount of write-down | 1,756 | 1,960 | 18,008 |
Amount of reversal of write- | - | - | - |
down | |||
The reversal of write-down was due to an increase in net realisable value, as a result of an increase in new orders with positive sales activities.
15. Trade and other receivables
Details of trade and other receivables are as follows: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
Accounts receivable | 104,305 | 97,422 | 895,180 |
Notes receivable and | 6,908 | 5,694 | 52,322 |
electronically recorded | |||
monetary claims-operating | |||
Other receivables | 2,694 | 3,078 | 28,280 |
Allowance for doubtful accounts | (3,061) | (2,855) | (26,235) |
Total | 110,847 | 103,339 | 949,547 |
The credit terms for customers are set between 90 days and 120 days on average.
Refer to Note 21 "Financial instruments" for credit risk management and fair value of trade and other receivables.
- 62 -
16. Interest-bearing debt
Details of interest-bearing debt are as follows: | |||||
(Millions of | (Millions of | (Thousands of | Average | ||
Yen) | Yen) | U.S. Dollars | |||
interest rate | Due | ||||
(Note 2)) | |||||
(%) | |||||
As at 31 March As at 31 March As at 31 March | |||||
(i) | |||||
2019 | 2020 | 2020 | |||
Long-term bank loans (excluding current portion) | 327 | 234 | 2,154 | - | 2022-2032 |
Current portion of long-term bank loans | 1 | 19 | 175 | - | - |
Short-term bank loans | 1,648 | 864 | 7,941 | 1.48% | - |
Long-term lease obligations | 577 | 14,237 | 130,823 | - | 2022‐2049 |
Short-term lease obligations | 285 | 6,610 | 60,741 | - | - |
Total interest-bearing debt | 2,838 | 21,966 | 201,834 | ||
Total non-current debt | 904 | 14,472 | 132,977 | ||
Total current debt | 1,934 | 7,494 | 68,857 | ||
Note:
(i) Interest rates are based on the weighted-average rates that applied to the balances at the end of each fiscal year.
The obligations under leases are secured by the leased assets for which the lessor has ownership. There is no debt with covenants as at 31 March 2020.
Details of the remaining contractual maturity for long-term borrowings and its fair values are set out in Note 21 "Financial instruments".
- 63 -
The changes in liabilities arising from financial activities are as follows:
(Millions of Yen) | ||||||||||||||
Non-cash changes | ||||||||||||||
Exchange | As at 31 March | |||||||||||||
As at 1 April 2018 | Cash flow | Change of scope | differences on | |||||||||||
Others | 2019 | |||||||||||||
of consolidation | translation of | |||||||||||||
foreign operations | ||||||||||||||
Short-term bank | 1,658 | (10) | 1,648 | |||||||||||
- | - | - | ||||||||||||
loans | ||||||||||||||
Long-term bank | 9 | (20) | 340 | (0) | - | 328 | ||||||||
loans | ||||||||||||||
Bond | 14 | (14) | - | - | - | - | ||||||||
Finance lease | 672 | (251) | - | (35) | 476 | 862 | ||||||||
obligations | ||||||||||||||
Total | 2,353 | (284) | 340 | (46) | 476 | 2,838 | ||||||||
(Millions of Yen) | ||||||||||||||
Non-cash changes | ||||||||||||||
Change in | As at 1 April | Exchange | ||||||||||||
As at 1 April | accounting | 2019 | Cash flow | differences on | As at 31 March | |||||||||
2019 | policy | (after | translation of | Others | 2020 | |||||||||
(IFRS 16) | adjustment) | foreign | ||||||||||||
operations | ||||||||||||||
Short-term bank | 1,648 | - | 1,648 | (775) | (9) | - | 864 | |||||||
loans | ||||||||||||||
Long-term bank | 328 | - | 328 | (134) | 59 | - | 253 | |||||||
loans | ||||||||||||||
Lease obligations | 862 | 21,375 | 22,237 | (7,547) | (630) | 6,787 | 20,848 | |||||||
Total | 2,838 | 21,375 | 24,214 | (8,456) | (579) | 6,787 | 21,966 | |||||||
(Thousands of U.S. Dollars (Note 2) | ||||||||||||||
Non-cash changes | ||||||||||||||
Change in | As at 1 April | Exchange | ||||||||||||
As at 1 April | accounting | 2019 | Cash flow | differences on | As at 31 March | |||||||||
2019 | policy | (after | translation of | Others | 2020 | |||||||||
(IFRS 16) | adjustment) | foreign | ||||||||||||
operations | ||||||||||||||
Short-term bank | 15,143 | - | 15,143 | (7,123) | (79) | - | 7,941 | |||||||
loans | ||||||||||||||
Long-term bank | 3,015 | - | 3,015 | (1,231) | 545 | - | 2,329 | |||||||
loans | ||||||||||||||
Lease obligations | 7,922 | 196,410 | 204,332 | (69,346) | (5,789) | 62,367 | 191,564 | |||||||
Total | 26,080 | 196,410 | 222,490 | (77,700) | (5,323) | 62,367 | 201,834 |
- 64 -
17. Retirement benefit plans
The Group has contributory defined contribution plans and defined benefit plans, and non-contributory defined benefit plans. The accounting policies adopted by the Group for retirement benefit plans are stated in Note 3 "Significant accounting policies (19) Retirement benefit costs".
The Company and its domestic subsidiaries mainly have defined contribution plans. Overseas subsidiaries have benefit plans required by the local laws and regulations of each country. Unless a defined benefit plan is required by the laws of the country in which the overseas subsidiaries operate, a defined contribution plan has been put into place. The plan in the U.K. represents a substantial portion of the pension plans of the Group, where it is the closed plan that stopped new registrations. Management believes that general risks, such as investment, credit and salary risks are not significant in the plan.
The Group does not have retirement benefit plans other than pension plans and lump-sum retirement allowances.
(1) Defined benefit plans
The amounts included in the consolidated statement of financial position arising from the Group's obligations in respect of its defined benefit plans are as follows:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |
Dollars (Note 2)) | |||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
Present value of funded defined benefit obligation | 6,610 | 7,036 | 64,651 |
Fair value of plan assets | (3,907) | (3,889) | (35,736) |
Total | 2,704 | 3,147 | 28,915 |
Effect of changes to the asset ceiling | 66 | 56 | 513 |
Net liability arising from defined benefit plans | |||
obligations | 2,770 | 3,203 | 29,428 |
Balance in the consolidated statement of financial | |||
position | |||
Liability | 2,770 | 3,203 | 29,428 |
Asset (Other non-current assets) | - | - | - |
- 65 -
Amounts recognised in the consolidated statement of comprehensive income in respect of these defined benefit plans are as follows:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||
(Note 2)) | ||||
For the year ended | For the year ended | For the year ended | ||
31 March 2019 | 31 March 2020 | 31 March 2020 | ||
Service cost | ||||
Current service cost | 626 | 1,192 | 10,954 | |
Past service cost | - | (274) | (2,514) | |
Net interest expense | 36 | 47 | 432 | |
Components of defined benefit costs | 662 | 966 | 8,872 | |
recognised in profit or loss | ||||
Remeasurement of net defined benefit | ||||
liability | ||||
Return on plan assets | 138 | 81 | 743 | |
Actuarial gains and losses arising from | (8) | (24) | (216) | |
changes in demographic assumptions | ||||
Actuarial gains and losses arising from | 158 | (105) | (964) | |
changes in financial assumptions | ||||
Actuarial gains and losses arising from | (58) | 102 | 934 | |
experience adjustments | ||||
Adjustments for restrictions on the | 61 | (5) | (42) | |
defined benefit asset | ||||
Components of defined benefit costs | 293 | 50 | 456 | |
recognised in other comprehensive | ||||
income | ||||
Total | 955 | 1,015 | 9,328 | |
Service cost and net interest expense are included in 'Employee benefits expense' and 'Finance cost' in the consolidated statement of comprehensive income.
Movements in the present value of the defined benefit obligations are as follows: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
For the year ended | For the year ended | For the year ended | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Beginning balance | 6,033 | 6,610 | 60,738 |
Current service cost | 626 | 1,192 | 10,954 |
Interest cost | 125 | 116 | 1,065 |
Remeasurement (gains)/losses | |||
Actuarial gains and losses arising from | (8) | (24) | (216) |
changes in demographic assumptions | |||
Actuarial gains and losses arising from | 158 | (105) | (964) |
changes in financial assumptions | |||
Actuarial gains and losses arising from | (58) | 102 | 934 |
experience adjustments | |||
Past service cost | - | (274) | (2,514) |
Decrease due to settlements | - | (12) | (111) |
Benefits paid | (267) | (190) | (1,743) |
Effect of foreign currency exchange | 1 | (380) | (3,492) |
differences | |||
Ending balance | 6,610 | 7,036 | 64,651 |
Movements in the present value of the plan assets are as follows:
- 66 -
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||
(Note 2)) | ||||
For the year ended | For the year ended | For the year ended | ||
31 March 2019 | 31 March 2020 | 31 March 2020 | ||
Beginning balance | 3,906 | 3,907 | 35,896 | |
Interest income | 89 | 632 | ||
69 | ||||
Remeasurement gain (loss) | ||||
Return on plan assets (excluding amounts | (138) | (81) | (743) | |
included in net interest expense) | ||||
Contributions from the employer | 344 | 283 | 2,603 | |
Benefits paid | (210) | (212) | (1,950) | |
Effect of foreign currency exchange | (84) | (76) | (703) | |
differences | ||||
Ending balance | 3,907 | 3,889 | 35,736 | |
Movements in the effect of changes to the asset ceiling are as follows: | ||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||
(Note 2)) | ||||
For the year ended | For the year ended | For the year ended | ||
31 March 2019 | 31 March 2020 | 31 March 2020 | ||
Beginning balance | - | 66 | 606 | |
Remeasurement gain (loss) | ||||
Effect of changes in the asset ceiling | 61 | (5) | (42) | |
Effect of foreign currency exchange | ||||
differences | 5 | (6) | (51) | |
Ending balance | 66 | 56 | 513 | |
The fair values of major categories of plan assets as at 31 March 2019 and 2020, are as follows: | ||||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||
(Note 2)) | ||||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | ||
Cash and cash equivalents | 959 | 1,240 | 11,397 | |
Equity instruments - Foreign equity | 1,966 | 1,768 | 16,244 | |
instruments | ||||
Debt instruments - Foreign governmental | 181 | 167 | 1,539 | |
bonds | ||||
Debt instruments - Foreign bonds | 779 | 688 | 6,324 | |
Others | 20 | 25 | 232 | |
Total | 3,907 | 3,889 | 35,736 | |
The fair values of financial instruments are measured at quoted market price in active markets. No transferable instrument is included in plan assets.
The principal assumptions used for the purposes of the actuarial valuations were as follows:
As at 31 March 2019 | As at 31 March 2020 | ||
Discount rate | 2.3% | 2.4% |
The Group believes there is no material impact on operating results, financial positions and cash flows due to the defined benefit plan of the Group, including the amount, timing and uncertainly of future cash flows.
- 67 -
(2) Defined contribution plans
The total expense recognised was 2,416 million yen and 2,371 million yen (21,787 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.
(3) Severance payments
Under certain circumstances (such as retirement before the predetermined retirement date), additional payments are made upon retirement. The total expense recognised was 1,924 million yen and 1,770 million yen (16,264 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.
- 68 -
18. Provisions
Details of provisions are as follows: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
Asset retirement obligation | 2,620 | 2,559 | 23,512 |
Warranties provision | 1,249 | 1,214 | 11,157 |
Total | 3,868 | 3,773 | 34,669 |
Non-current liabilities | 2,607 | ||
2,539 | 23,327 | ||
Current liabilities | 1,261 | 1,234 | 11,342 |
An analysis of the change in provisions is as follows:
(Millions of Yen) | ||||
Asset retirement obligation | Warranties provision | Total | ||
Balance at 1 April 2019 | 1,249 | 3,868 | ||
2,620 | ||||
Provision for the year | 77 | 908 | ||
832 | ||||
Acquisitions through business combinations | 20 | - | 20 | |
Interest cost associated with passage of time | 18 | - | 18 | |
Reduction resulting from settlement for the year | (146) | (822) | (968) | |
Effect of foreign currency exchange differences | (28) | (44) | (73) | |
Balance at 31 March 2020 | 2,559 | 1,214 | 3,773 | |
(Thousands of U.S. Dollars (Note 2)) | ||||
Asset retirement obligation | Warranties provision | Total | ||
Balance at 1 April 2019 | 11,473 | 35,542 | ||
24,070 | ||||
Provision for the year | 705 | |||
7,642 | 8,347 | |||
Acquisitions through business combinations | 182 | - | 182 | |
Interest cost associated with passage of time | 161 | - | 161 | |
Reduction resulting from settlement for the year | (1,343) | (7,553) | (8,896) | |
Effect of foreign currency exchange differences | (262) | (405) | (667) | |
Balance at 31 March 2020 | 23,512 | 11,157 | 34,669 |
Note:
Refer to Note 3 "Significant accounting policies (20) Provisions and contingent liabilities assumed in a business combination" for details of each provision.
- 69 -
19. Trade and other payables
Details of trade and other payables are as follows: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
Accounts payable | 29,871 | 31,296 | 287,571 |
Notes payable, trade | 6,903 | 5,943 | 54,605 |
Processing cost payable | 849 | 830 | 7,629 |
Other payables | 16,823 | 23,968 | 220,232 |
Notes payable for capital investment | 442 | 858 | 7,885 |
Total | 54,887 | 62,895 | 577,922 |
Trade notes payable are due 120 days on average.
Accounts payable are due 30 to 60 days from the invoice date in Asia except for Japan, and due 90 to 120 days from the invoice date in Japan. Accounts payable in Europe and U.S.A. are mainly payables related to intragroup transactions; thus, upon consolidation, these trade accounts payable are eliminated. The Group arranges cash pooling for Japan, Europe and U.S.A. to ensure that all payables are paid within the pre-agreed credit terms.
- 70 -
20. Share capital and other equity items
(1) Share capital and capital reserves | |||||||
Number of | Number of issued | Number of | Share capital | Capital | Share capital | Capital | |
authorised shares | shares | outstanding shares | reserves | reserves | |||
(Ordinary shares | (Ordinary shares | (Ordinary shares | (Millions of | (Millions of | (Thousands of (Thousands of | ||
with no par value)with no par value)with no par value) | Yen) | Yen) | U.S. Dollars | U.S. Dollars | |||
(Note 2)) | (Note 2)) | ||||||
Balance at | |||||||
1 April 2018 | 1,250,519,400 | 381,436,420 | 379,514,346 | 6,264 | 15,899 | 57,560 | 146,087 |
Increase (ii) | - | - | 453,257 | - | - | - | - |
Balance at | |||||||
31 March 2019 | 1,250,519,400 | 381,436,420 | 379,967,603 | 6,264 | 15,899 | 57,560 | 146,087 |
Decrease (i), (ii) | - | 3,085,200 | 4,967,819 | - | - | - | - |
Balance at | |||||||
31 March 2020 | 1,250,519,400 | 378,351,220 | 374,999,784 | 6,264 | 15,899 | 57,560 | 146,087 |
Note: |
- Decrease in number of issued shares is due to cancellation of treasury shares.
- Increase or decrease in number of outstanding shares is due to increase or decrease in treasury shares.
-
Treasury shares and other capital reserves
① Treasury shares
Numbers of shares | Amount | |
(Millions of Yen) | ||
Balance at 1 April 2018 | 1,922,074 | 10,886 |
Repurchase of odd-lot shares | 347 | 2 |
Disposal of odd-lot shares | (4) | (0) |
Decrease on exercise of stock options | (453,600) | (2,569) |
Balance at 31 March 2019 | 1,468,817 | 8,319 |
Repurchase of treasury shares | 5,295,700 | 44,256 |
Cancellation of treasury shares | (3,085,200) | (22,308) |
Repurchase of odd-lot shares | 519 | 5 |
Decrease on exercise of stock options | (328,400) | (2,309) |
Balance at 31 March 2020 | 3,351,436 | 27,963 |
- 71 -
Amount | |||||||||
Numbers of shares | (Thousands of U.S. Dollars | ||||||||
(Note 2)) | |||||||||
Balance at 31 March 2019 | 1,468,817 | 76,441 | |||||||
Repurchase of treasury shares | 5,295,700 | 406,656 | |||||||
Cancellation of treasury shares | (3,085,200) | (204,982) | |||||||
Repurchase of odd-lot shares | 519 | 45 | |||||||
Decrease on exercise of stock options | (328,400) | (21,214) | |||||||
Balance at 31 March 2020 | 3,351,436 | 256,945 | |||||||
② Other capital reserves | |||||||||
Gain (loss) on | |||||||||
disposal of treasury | Stock option (i) | Others | Total | ||||||
shares | |||||||||
(Millions of Yen) | (Millions of Yen) | (Millions of Yen) | (Millions of Yen) | ||||||
Balance at 1 April 2018 | (8,672) | 3,114 | (1,102) | (6,660) | |||||
Disposal of treasury shares | (600) | (370) | - | (969) | |||||
Share-based payments (i) | - | 195 | - | 195 | |||||
Balance at 31 March 2019 | (9,272) | 2,940 | (1,102) | (7,434) | |||||
Repurchase of treasury shares | - | - | (22) | (22) | |||||
Disposal of treasury shares | (771) | (261) | - | (1,032) | |||||
Share-based payments (i) | - | 125 | - | 125 | |||||
Change in non-controlling interests (ii) | - | - | (65) | (65) | |||||
Balance at 31 March 2020 | (10,043) | 2,804 | (1,189) | (8,428) | |||||
Gain (loss) on | |||||||||
disposal of treasury | Stock option (i) | Others | Total | ||||||
shares | |||||||||
(Thousands of U.S. | (Thousands of U.S. | (Thousands of U.S. | (Thousands of U.S. | ||||||
Dollars (Note 2)) | Dollars (Note 2)) | Dollars (Note 2)) | Dollars (Note 2)) | ||||||
Balance at 31 March 2019 | (85,197) | 27,012 | (10,126) | (68,311) | |||||
Repurchase of treasury shares | - | - | (203) | (203) | |||||
Disposal of treasury shares | (7,082) | (2,400) | - | (9,483) | |||||
Share-based payments (i) | - | 1,153 | - | 1,153 | |||||
Change in non-controlling interests (ii) | - | - | (597) | (597) | |||||
Balance at 31 March 2020 | (92,280) | 25,764 | (10,926) | (77,442) | |||||
- Refer to Note 22 "Share-based payments" for details of stock options.
- The Group acquired 5.0% of outstanding shares in HOYA LENS GUANGZHOU LTD. As a result, the ownership interest of the Group increased to 100%. 65 million yen (597 thousand U.S. dollars), the difference between the decrease of non-controlling interests (i.e., proportional interests of the carrying amount of the net assets) and the consideration paid for the shares is included in 'Other capital reserves' in the consolidated statement of financial position.
- 72 -
(3) Retained earnings and dividends | |||||||||
Amount | |||||||||
(Millions of Yen) | |||||||||
Balance at 1 April 2018 | 529,818 | ||||||||
Profit for the year (attributable to owners of the Company) | 122,103 | ||||||||
Dividends | (34,164) | ||||||||
Transfer to retained earnings | (297) | ||||||||
Balance at 31 March 2019 | 617,459 | ||||||||
Cumulative effect of change in accounting policy | 533 | ||||||||
Profit for the year (attributable to owners of the Company) | 114,406 | ||||||||
Cancellation of treasury shares | (22,308) | ||||||||
Dividends | (34,064) | ||||||||
Transfer to retained earnings from other comprehensive income | 32 | ||||||||
Balance at 31 March 2020 | 676,058 | ||||||||
Amount | |||||||||
(Thousands of U.S. Dollars (Note 2)) | |||||||||
Balance at 31 March 2019 | 5,673,614 | ||||||||
Cumulative effect of change in accounting policy | 4,895 | ||||||||
Profit for the year (attributable to owners of the Company) | 1,051,239 | ||||||||
Cancellation of treasury shares | (204,982) | ||||||||
Dividends | (313,006) | ||||||||
Transfer to retained earnings from other comprehensive income | 296 | ||||||||
Balance at 31 March 2020 | 6,212,056 | ||||||||
Details of dividends are as follows: | |||||||||
Dividends per | Dividends per | Total dividends | Total dividends | ||||||
Date of resolution | share | share | (Millions of | (Thousands of | Record date | Effective date | |||
(U.S. Dollars | U.S. Dollars | ||||||||
(Yen) | Yen) | ||||||||
(Note 2)) | (Note 2)) | ||||||||
24 May 2018 | 45 | 0.41 | 17,078 | 156,925 | 31 March 2018 | 1 June 2018 | |||
31 October 2018 | 45 | 0.41 | 17,086 | 157,000 | 30 September 2018 | 30 November 2018 | |||
23 May 2019 | 45 | 0.41 | 17,099 | 157,112 | 31 March 2019 | 3 June 2019 | |||
29 October 2019 | 45 | 0.41 | 16,966 | 155,894 | 30 September 2019 | 29 November 2019 | |||
20 May 2020 | 45 | 0.41 | 16,875 | 155,058 | 31 March 2020 | 8 June 2020 | |||
Dividends payable are included in the line item 'Other short-term financial liabilities' in the consolidated statement of financial position.
- 73 -
(4) Non-controlling interests | |
Amount | |
(Millions of Yen) | |
Balance at 1 April 2018 | 4,484 |
Profit for the year, attributable to non-controlling interests | (31) |
Other comprehensive income | (140) |
Dividends | (30) |
Increase due to acquisition of subsidiaries | 202 |
Increase | 67 |
Balance at 31 March 2019 | 4,552 |
Profit for the year, attributable to non-controlling interests | 181 |
Other comprehensive income | (220) |
Increase due to establishment of subsidiaries | 187 |
Decrease due to acquisition of non-controlling interests | (84) |
Put option granted to non-controlling interests, etc.(i) | (20,392) |
Balance at 31 March 2020 | (15,777) |
Amount | |
(Thousands of U.S. Dollars (Note 2)) | |
Balance at 31 March 2019 | 41,824 |
Profit for the year, attributable to non-controlling interests | 1,659 |
Other comprehensive income | (2,019) |
Increase due to establishment of subsidiaries | 1,715 |
Decrease due to acquisition of non-controlling interests | (775) |
Put option granted to non-controlling interests, etc.(i) | (187,372) |
Balance at 31 March 2020 | (144,968) |
- The Group recognised a financial liability at the present value of the expected future payment for the acquisition of additional shares of the joint venture which was established in this fiscal year based on the contract with the non-controlling shareholder.
- 74 -
21. Financial instruments
(1) Capital risk management
The Group manages its capital for continuous growth and to maximise the corporate value of the Group.
The net debt and equity of the Group are as follows: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. | |
Dollars (Note 2)) | |||
As at | As at | As at | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Interest-bearing debt | 2,838 | 21,966 | 201,834 |
Less: Cash and cash equivalents | 293,397 | 317,982 | 2,921,820 |
Net debt | (290,559) | (296,016) | (2,719,986) |
Equity | 627,707 | 629,265 | 5,782,090 |
In order to maximise the corporate value of the Group, cash flows have been a priority of the Group management. As at 31 March 2019 and 2020, the Group maintained cash and cash equivalent balances in excess of interest-bearing debt balances. The Group is not subject to any externally imposed capital regulations as at 31 March 2020.
Details of interest-bearing debt and equity are described in Note 16 "Interest-bearing debt" and Note 20 "Share capital and other equity items", respectively.
(2) Significant accounting policies
Accounting policies and criteria for recognition of financial assets, financial liabilities, basis of measurement and recognition of income and expenses are described in Note 3 "Significant accounting policies".
- 75 -
(3) Categories of financial instruments
(Millions of Yen) | (Millions of Yen) | (Thousands of | |
U.S. Dollars (Note 2)) | |||
As at | As at | As at | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Financial assets | |||
Financial assets measured at amortised cost | |||
Trade and other receivables | 110,847 | 103,339 | 949,547 |
Other financial assets (ii) | 17,370 | 16,490 | 151,518 |
FVTOCI financial assets (iv) | |||
Other financial assets (ii) | 29,863 | 30,789 | 282,906 |
Cash and cash equivalents | 293,397 | 317,982 | 2,921,820 |
Financial liabilities | |||
FVTPL financial liabilities (v) | |||
Trade and other payables | 1,186 | 3,460 | 31,792 |
Other financial liabilities (iii) | 3,082 | 542 | 4,976 |
Financial liabilities measured at amortised cost | |||
Trade and other payables | 53,701 | 59,435 | 546,131 |
Interest-bearing debt | 2,838 | 21,966 | 201,834 |
Other financial liabilities (iii) | 8,500 | 26,205 | 240,785 |
Note:
- The items above are not included in discontinued operations and disposal groups held for sale. The Group does not have derivative instruments designated as hedging instruments. Likewise, the Group does not have financial assets or financial liabilities using the fair value option.
- Other financial assets are included in 'Long-term financial assets' or 'Other short-term financial assets' in the consolidated statement of financial position.
- Other financial liabilities are included in 'Other long-term/short-term financial liabilities' in the consolidated statement of financial position.
- FVTOCI financial assets mainly consist of unlisted shares.
- FVTPL financial liabilities mainly consist of contingent considerations resulting from business combinations.
- Financial assets or liabilities to be offset as at 31 March 2019 and 2020, are immaterial.
(4) Financial risk management
In its operations, the Group is exposed to various financial risks. The Group undertakes risk management steps to minimise the effects of these financial risks. In an effort to manage these risks, the Group's risk management approach is to eliminate the sources of these risks or to minimise the risks that are not avoidable.
The Group does not enter into or trade financial instruments, including derivative financial instruments, for speculative purposes. In certain cases, the Group obtains additional borrowings from financial institutions to react to temporary cash shortages or uses forward foreign exchange contracts to sustain cash flows. The above financial risks are managed by the financial department of the Group.
- 76 -
(5) Market risk management
The Group is exposed to risks arising from changes in the economic environment and financial markets. The factors of the risk relating to financial markets are fluctuation risk of foreign currency exchange rates, interest rates, and fair value of equity instruments.
- Foreign currency risk
1) Foreign currency risk management
As the Group's businesses have expanded globally, foreign exchange fluctuations, in particular from the Thai Baht, the Euro and the U.S. dollar, have a significant impact on the Group's financial results. If the Japanese yen appreciates against these currencies, both sales and profit stated in the Japanese yen might decrease even though sales and profits stated in local currencies have increased.
The Group intends to marry major currencies the Group uses (i.e., Euro, U.S. dollar and Yen) in settlements of receivables/payables resulting from operating activities. Specifically, the subsidiaries that continuously conduct import or export transactions retain foreign currencies obtained from exports of goods for payables on imported supplies. This enables the Group to mitigate foreign currency risk. On the other hand, as the Company has multiple SBUs and conducts its own finance and dividend payments to the Company's shareholders, and the holding companies under the Company receive dividends from their subsidiaries and distribute them to the Company and/or other group companies, the Group's foreign currency-dominated balances in receivables, liabilities and/or bank deposits may not fully offset each other. This might cause significant gains or losses on foreign exchange differences when the Yen appreciates or depreciates against the U.S. dollar or the Euro, or when the Euro appreciates or depreciates against the U.S. dollar.
2) Foreign currency sensitivity analysis
The chart below shows the impact on profit and equity of a 1% appreciation of the Yen against the Thai Baht, the Euro and the U.S. dollar with the assumption that the exchange rates for other currencies are constant.
For the year ended 31 March 2019 | For the year ended 31 March 2020 | ||
Average exchange rate | |||
(Yen per each currency) | |||
Thai Baht | 3.43 | 3.51 | |
Euro | 128.26 | 120.85 | |
U.S. dollar | 110.07 | 108.95 | |
Impact on profit for the year | |||
(Millions of Yen) | |||
Thai Baht | (227) | (202) | |
Euro | (9) | (50) | |
U.S. dollar | (414) | (325) | |
Impact on equity | |||
(Millions of Yen) | |||
Thai Baht | (353) | (294) | |
Euro | (330) | (380) | |
U.S. dollar | (649) | (581) | |
For the year ended 31 March 2020 | |||
Impact on profit for the year | |||
(Thousands of U.S. Dollars (Note 2)) | |||
Thai Baht | (1,858) | ||
Euro | (458) | ||
U.S. dollar | (2,985) | ||
Impact on equity | |||
(Thousands of U.S. Dollars (Note 2)) | |||
Thai Baht | (2,702) | ||
Euro | (3,494) | ||
U.S. dollar | (5,335) |
- 77 -
Note:
Numbers in parentheses are the amounts of negative impact on profit and equity resulting from a 1% appreciation of the Yen. The amounts above represent the impact on the consolidated financial statements of the Group resulting from foreign currency conversion and not the impact on the Group's cash flows or operations themselves.
Likewise, the tables below show the impact of a 1% appreciation of functional currencies of the Company and its holding company within the Group on their receivables/liabilities and bank deposits denominated in foreign currencies on the assumption that exchange rates for other currencies are constant. The information about the holding companies with immaterial risk is not included in the tables below.
2)-1. Parent company (the Company)
(Millions of Yen) | |||||
Euro | U.S. dollar | ||||
31 March 2019 | 31 March 2020 | 31 March 2019 | 31 March 2020 | ||
Trade and other receivables | (26) | (28) | (70) | (74) | |
Trade and other payables | 2 | 1 | 10 | 13 | |
Short-term financial assets | (0) | (0) | (0) | (0) | |
Short-terminterest-bearing debt | - | - | 128 | - | |
Cash and cash equivalents | (12) | (3) | (108) | (51) | |
Total | (36) | (29) | (40) | (113) | |
(Thousands of U.S. Dollars (Note 2)) | |||||
Euro | U.S. dollar | ||||
31 March 2020 | 31 March 2020 | ||||
Trade and other receivables | (254) | (681) | |||
Trade and other payables | 14 | 116 | |||
Short-term financial assets | (0) | (1) | |||
Short-terminterest-bearing debt | - | - | |||
Cash and cash equivalents | (25) | (472) | |||
Total | (265) | (1,038) | |||
Note:
Numbers in parentheses are the amounts of negative impact on profit and equity resulting from a 1% appreciation of the Yen. A 1% depreciation of the Yen has a positive impact in the same amount.
Intercompany receivables/payables are included in the calculation of the impact as they cause foreign exchange gain or loss in the process of translation.
2)-2. Holding company (Europe)
(Millions of Yen) | ||||||
Yen | U.S. dollar | |||||
31 March 2019 | 31 March 2020 | 31 March 2019 | 31 March 2020 | |||
Cash and cash equivalents | (3) | (0) | (1) | (35) | ||
Total | (3) | (0) | (1) | (35) | ||
- 78 -
(Thousands of U.S. Dollars (Note 2))
Yen | U.S. dollar | ||
31 March 2020 | 31 March 2020 | ||
Cash and cash equivalents | (0) | (318) | |
Total | (0) | (318) | |
Note:
Numbers in parentheses are the amounts of negative impact on profit and equity resulting from a 1% appreciation of the Euro. A 1% depreciation of the Euro has a positive impact in the same amount.
Intercompany receivables/payables are included in the calculation of the impact as they cause foreign exchange gain or loss in the process of translation.
3) Currency derivatives
The Group's policy prohibits the use of derivative instruments such as forward foreign exchange contracts, except in certain circumstances in which the use of such derivatives is determined to be beneficial. In such case, the Group can enter into contracts upon obtaining formal approval from the Chief Financial Officer ("CFO") of the Group in accordance with its Group headquarters approval process.
In order to economically hedge foreign currency exposures on intercompany receivables, payables and dividends, forward foreign exchange contracts are occasionally entered into. In these cases, the same approval policy as that stated above is adhered to.
Details of the forward foreign exchange contracts at the end of each reporting period are as follows:
(Millions of Yen)
For the year ended | Average | Foreign | Notional | Fair value | ||
31 March 2019 | exchange rate currency (mil) | amount | ||||
Forward foreign exchange contracts | ||||||
N/A | ||||||
(Millions of Yen) | (Thousands of U.S. Dollars (Note 2)) | |||||
For the year ended | Average | Foreign | Notional | Fair value | Notional | Fair value |
31 March 2020 | exchange rate currency (mil) | amount | amount |
Forward foreign exchange contracts
N/A
- 79 -
- Interest rate risk management
The majority of the interest-bearing debt consists of bonds with fixed interest rates. The Group's cash and cash equivalents exceed the interest-bearing debt, and currently, the impact of interest expense on the Group's profit/loss is immaterial. Therefore, the Group considers the interest rate risk to be immaterial and has not performed sensitivity analyses such as Basis Point Value.
- Price risks management in equity instruments
The Group is exposed to equity price risks arising from equity instruments (i.e., listed shares). These investments are held from a viewpoint of business strategy, not for short-term trading purposes. The Group does not sell these investments frequently and the Group periodically reviews the fair value of these instruments as well as the financial condition of investees.
The sensitivity analysis has been based on the exposure to the price of equity instruments (listed shares) at the end of the reporting period. If equity prices increase or decrease by 5%, accumulated other comprehensive income (pre-tax) would change by 75 million yen and 51 million yen (463 thousand U.S. dollars) as at 31 March 2019 and 2020, respectively, as a result of changes in fair value of the equity instruments.
- 80 -
(6) Credit risk management
Credit risk is the risk that a counterparty will default on its contractual obligations resulting in a financial loss to the Group. The Group manages its credit risk by setting credit limits that are approved by the authorised personnel of each SBU.
The main customers for the Information Technology business are globalised companies that have relatively large-scale and stable financial conditions. On the other hand, credit losses were incurred on a sporadic basis in the Life Care business as those products were sold to relatively small and diversified customers, such as end consumers, retailers, and medical institutions. Accordingly, no significant credit losses were incurred in the past. A division in the Life Care business that sells goods to medical institutions and operates wholesale businesses in certain countries has some past-due receivables due to the financial conditions of those medical institutions or customers. Credit limits have been set for those customers to minimise the loss from a failure to collect the receivables.
Trade receivables consist of a large number of customers across a diverse range of industries and geographical areas. The Group has neither significant credit risk exposure for a specific customer or customer group categorised by similarity, nor concentration of credit risk over 5% of total financial assets as at 31 March 2020.
The carrying amounts after impairment presented in the consolidated financial statements are the maximum exposure for the Group's credit risk without considering the appraised value of the related collateral.
The Group continuously monitors the financial status of customers that appear to represent a credit risk in collecting receivables, including restructured receivables. Based on this monitoring, the Group sets the allowance for doubtful accounts considering the collectability of the receivables.
Each financial asset should be recognised as a credit-impaired financial asset if the debtor claims legal proceedings such as bankruptcy, company reorganization, civil rehabilitation and special liquidation in cases of overdue payments despite performance by enforcement. The Group directly writes off an asset by reducing the total carrying amount in cases where collection of contractual cashflow is not reasonably expected, entirely or partially.
- 81 -
Impaired or past-due financial assets
The following table provides the ageing details of the financial assets not yet due and the financial assets past-due but not impaired at the end of the reporting period:
(Millions of Yen)
Balance at 31 March 2019 | Within due | Overdue amounts | ||||||
Total | Within 30 | 91 to 120 | Over 120 | |||||
date | 31 to 60 days 61 to 90 days | |||||||
days | days | days | ||||||
Trade and other receivables | ||||||||
(gross) | 113,908 | 97,373 | 8,185 | 2,742 | 1,035 | 647 | 3,926 | |
Allowance for doubtful accounts | (3,061) | (431) | (76) | (99) | (89) | (253) | (2,114) | |
Trade and other receivables (net) | 110,847 | 96,942 | 8,109 | 2,643 | 946 | 394 | 1,812 | |
Other financial assets (gross) | 18,099 | 17,309 | 1 | 5 | 78 | 130 | 575 | |
Allowance for doubtful accounts | (729) | (2) | - | (5) | (78) | (130) | (513) | |
Other financial assets (net) | 17,370 | 17,307 | 1 | - | - | - | 61 | |
(Millions of Yen) | ||||||||
Balance at 31 March 2020 | Within due | Overdue amounts | ||||||
Total | Within 30 | 91 to 120 | Over 120 | |||||
date | 31 to 60 days 61 to 90 days | |||||||
days | days | days | ||||||
Trade and other receivables | ||||||||
(gross) | 106,194 | 89,830 | 7,709 | 2,482 | 1,099 | 1,077 | 3,997 | |
Allowance for doubtful accounts | (2,855) | (518) | (154) | (135) | (105) | (262) | (1,682) | |
Trade and other receivables (net) | 103,339 | 89,312 | 7,555 | 2,347 | 994 | 815 | 2,316 | |
Other financial assets (gross) | 1 | |||||||
16,889 | 16,449 | - | - | - | 439 | |||
Allowance for doubtful accounts | (399) | (2) | - | - | - | (1) | (396) | |
Other financial assets (net) | 16,490 | 16,447 | - | - | - | - | 43 | |
(Thousands of U.S. Dollars (Note 2)) | ||||||||
Balance at 31 March 2020 | Within due | Overdue amounts | ||||||
Total | Within 30 | 91 to 120 | Over 120 | |||||
date | 31 to 60 days 61 to 90 days | |||||||
days | days | days | ||||||
Trade and other receivables | ||||||||
(gross) | 975,783 | 825,418 | 70,834 | 22,808 | 10,102 | 9,892 | 36,729 | |
Allowance for doubtful accounts | (26,235) | (4,759) | (1,413) | (1,239) | (966) | (2,406) | (15,453) | |
Trade and other receivables (net) | 949,547 | 820,658 | 69,422 | 21,569 | 9,136 | 7,486 | 21,276 | |
Other financial assets (gross) | 155,188 | 151,143 | - | - | - | 13 | 4,032 | |
Allowance for doubtful accounts | (3,670) | (19) | - | - | - | (13) | (3,638) | |
Other financial assets (net) | 151,518 | 151,124 | - | - | - | - | 394 | |
The Group does not hold any collateral or other credit enhancements on the above financial assets, excluding the following: As at 31 March 2019
Current portion of long-term loans to subsidiaries and affiliates of 8,248 million yen As at 31 March 2020
Long-term loans to subsidiaries and affiliates of 8,454 million yen (77,685 thousand U.S. dollars) Details of collaterals are described in Note 30 "Related party disclosures".
- 82 -
In case of impairment of financial assets, the Group does not directly write off such assets by reducing the carrying amount; instead, it records an allowance for doubtful accounts. Movement in the allowance for doubtful accounts is as follows:
Balance at 1 April 2018 Provision for the year
Reduction resulting from settlement for the year Reduction for the year (reversal)
Other (foreign exchange translation gains or losses, etc.) Balance at 31 March 2019
Loss allowance at an amount equal to 12- month expected credit losses
-
-
-
-
-
-
Loss allowance at an amount equal to 12- month expected credit losses
(Millions of Yen) | |||
Loss allowance at an amount equal to | Total | ||
lifetime expected credit losses | |||
Non-credit- | Credit- | Trade and | |
impaired | impaired | other | |
financial | financial | receivables | |
assets | assets | ||
258 | 316 | 2,970 | 3,544 |
- | 246 | 636 | 882 |
(3) | (6) | (254) | (264) |
(25) | (45) | (145) | (215) |
(11) | (1) | (145) | (157) |
219 | 509 | 3,061 | 3,790 |
(Millions of Yen) | |||
Loss allowance at an amount equal to | Total | ||
lifetime expected credit losses | |||
Non-credit- | Credit- | Trade and | |
impaired | impaired | other | |
financial | financial | receivables | |
assets | assets |
Balance at 1 April 2019 | - | |||
Provision for the year | - | |||
Reduction resulting from settlement for the year | - | |||
Reduction for the year (reversal) | - | |||
Other (foreign exchange translation gains or losses, etc.) | - | |||
Balance at 31 March 2020 | - | |||
Loss | ||||
allowance at | ||||
an amount | ||||
equal to 12- | ||||
month | ||||
expected | ||||
credit losses | ||||
Balance at 1 April 2019 | - | |||
Provision for the year | - | |||
Reduction resulting from settlement for the year | - | |||
Reduction for the year (reversal) | - | |||
Other (foreign exchange translation gains or losses, etc.) | - | |||
Balance at 31 March 2020 | - | |||
219 | 509 | 3,061 | 3,790 |
- | 6 | 626 | 632 |
(185) | (70) | (495) | (751) |
- | (70) | (133) | (203) |
(7) | (3) | (203) | (214) |
27 | 372 | 2,855 | 3,255 |
(Thousands of U.S. Dollars (Note 2))
Loss allowance at an amount equal to Total lifetime expected credit losses
Non-credit- | Credit- | Trade and | |
impaired | impaired | other | |
financial | financial | receivables | |
assets | assets | ||
2,015 | 4,679 | 28,126 | 34,821 |
- | 58 | 5,754 | 5,812 |
(1,701) | (646) | (4,549) | (6,896) |
- | (640) | (1,226) | (1,866) |
(63) | (31) | (1,869) | (1,964) |
251 | 3,420 | 26,235 | 29,906 |
- 83 -
(7) Liquidity risk management
The ultimate responsibility for liquidity risk management rests with the CFO of the Group who is appointed by the board of directors. Based on the instructions from the CFO, the financial headquarters of the Group mainly manages the Group's liquidity risk by maintaining an appropriate level of retained earnings and credit facilities, and monitors the actual cash flows and forecasted cash flows. The credit lines for commercial paper are secured for temporary cash shortages due to dividends or bonus payments.
The following table details the contractual maturity of its financial liabilities, including derivative financial instruments but excluding guarantee liabilities:
(Millions of Yen) | ||||||||
Balance at 31 March 2019 | Carrying | Contractual Less than 1 1 to 2 years 2 to 3 years 3 to 4 years 4 to 5 years More than 5 | ||||||
amount | cash flows | year | years | |||||
Non-derivative liabilities | ||||||||
Trade and other payables | 54,887 | 54,887 | 54,887 | - | - | - | - | - |
Long-term bank loans (excluding | 327 | 327 | - | 52 | 19 | 19 | 19 | 216 |
current portion) | ||||||||
Current portion of long-term bank | 1 | 1 | 1 | - | - | - | - | - |
loans | ||||||||
Short-term bank loans | 1,648 | 1,648 | 1,648 | - | - | - | - | - |
Long-term lease obligations | 577 | 577 | - | 259 | 187 | 105 | 26 | - |
Short-term lease obligations | 285 | 285 | 285 | - | - | - | - | - |
Other financial liabilities | 11,582 | 11,582 | 646 | 8,875 | 1,933 | 129 | - | - |
Total | 69,308 | 69,308 | 57,467 | 9,186 | 2,139 | 254 | 46 | 216 |
(Millions of Yen) | ||||||||
Balance at 31 March 2020 | Carrying | Contractual Less than 1 1 to 2 years 2 to 3 years 3 to 4 years 4 to 5 years More than 5 | ||||||
amount | cash flows | year | years | |||||
Non-derivative liabilities | ||||||||
Trade and other payables | 62,895 | 62,895 | 62,895 | - | - | - | - | - |
Long-term bank loans (excluding | 234 | 234 | - | 38 | 19 | 19 | 19 | 140 |
current portion) | ||||||||
Current portion of long-term bank | 19 | 19 | 19 | - | - | - | - | - |
loans | ||||||||
Short-term bank loans | 864 | 864 | 864 | - | - | - | - | - |
Long-term lease obligations | 14,237 | 14,909 | - | 5,170 | 3,398 | 2,169 | 1,309 | 2,863 |
Short-term lease obligations | 6,610 | 6,610 | 6,610 | - | - | - | - | - |
Other financial liabilities | 26,746 | 29,709 | 2,824 | 2,922 | 522 | 4,125 | - | 19,318 |
Total | 111,607 | 115,242 | 73,212 | 8,129 | 3,939 | 6,312 | 1,328 | 22,321 |
- 84 -
(Thousands of U.S. Dollars (Note 2)) | |||||||||
Balance at 31 March 2020 | Carrying | Contractual Less than 1 1 to 2 years 2 to 3 years 3 to 4 years 4 to 5 years More than 5 | |||||||
amount | cash flows | year | years | ||||||
Non-derivative liabilities | |||||||||
Trade and other payables | 577,922 | 577,922 | 577,922 | - | - | - | - | - | |
Long-term bank loans (excluding | 2,154 | 2,154 | - | 347 | 172 | 172 | 172 | 1,288 | |
current portion) | |||||||||
Current portion of long-term bank | 175 | 175 | 175 | - | - | - | - | - | |
loans | |||||||||
Short-term bank loans | 7,941 | 7,941 | 7,941 | - | - | - | - | - | |
Long-term lease obligations | 130,823 | 136,992 | - | 47,501 | 31,227 | 19,928 | 12,028 | 26,308 | |
Short-term lease obligations | 60,741 | 60,741 | 60,741 | - | - | - | - | - | |
Other financial liabilities | 245,761 | 272,989 | 25,944 | 26,846 | 4,796 | 37,900 | - | 177,502 | |
Total | 1,025,517 | 1,058,914 | 672,723 | 74,694 | 36,196 | 58,000 | 12,199 | 205,098 | |
Note:
Guarantee liabilities have been excluded from the above table as the likelihood of execution has been determined as low.
The Company secures the financing methods below for temporary cash shortages due to dividends or bonus payments. Details of financing methods and status are as follows:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||
(Note 2)) | ||||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | ||
Bank overdraft | ||||
Used | - | - | - | |
Unused | 65,000 | 65,000 | 597,262 | |
Total | 65,000 | 65,000 | 597,262 | |
Commercial paper | ||||
Used | - | - | - | |
Unused | 50,000 | 50,000 | 459,432 | |
Total | 50,000 | 50,000 | 459,432 | |
- 85 -
(8) Fair value of financial assets and liabilities that are measured at fair value on a recurring basis
The following table provides an analysis of financial instruments that have been measured at fair value subsequent to initial recognition.
The fair values are categorised into Levels 1 to 3.
Level 1: Fair value derived from quoted prices in active markets for identical assets or liabilities.
Level 2: Fair value derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).
Level 3: Fair value derived from inputs for the asset or liability that are not based on observable market data (i.e., unobservable inputs).
- FVTOCI financial assets classified as Level 3 mainly consist of unlisted shares and are measured using valuation techniques such as net asset approach, discount cash flow method or comparable company method.
- FVTPL financial liabilities classified as Level 3 consist of contingent considerations and are measured based on the achievement of milestones considering time value of money.
- Financial instruments that are measured at fair value
(Millions of Yen) | ||||
As at 31 March 2019 | Level 1 | Level 2 | Level 3 | Total |
FVTOCI financial assets | 1,499 | - | 28,364 | 29,863 |
Total | 1,499 | - | 28,364 | 29,863 |
FVTPL financial liabilities | - | - | 4,268 | 4,268 |
Total | - | - | 4,268 | 4,268 |
(Millions of Yen) | ||||
As at 31 March 2020 | Level 1 | Level 2 | Level 3 | Total |
FVTOCI financial assets | 1,028 | - | 29,761 | 30,789 |
Total | 1,028 | - | 29,761 | 30,789 |
FVTPL financial liabilities | - | - | 4,001 | 4,001 |
Total | - | - | 4,001 | 4,001 |
(Thousands of U.S. Dollars (Note 2)) | ||||
As at 31 March 2020 | Level 1 | Level 2 | Level 3 | Total |
FVTOCI financial assets | 9,444 | - | 273,462 | 282,906 |
Total | 9,444 | - | 273,462 | 282,906 |
FVTPL financial liabilities | - | - | 36,768 | 36,768 |
Total | - | - | 36,768 | 36,768 |
Note: | ||||
As at 31 March 2019 |
No transfers occurred between Levels 1, 2 and 3 during the year ended 31 March 2019.
As at 31 March 2020
No transfers occurred between Levels 1, 2 and 3 during the year ended 31 March 2020.
- 86 -
- Reconciliation of financial assets categorised at Level 3 from beginning balance to ending balance
(Millions of Yen) | ||
For the year ended | Fair value measurement as at the end of the reporting period | |
31 March 2019 | ||
Available-for-sale financial assets | FVTPL financial liabilities | |
618 | 4,289 | |
Opening balance | ||
Total gains or losses recognised: | 382 | (165) |
- in profit or loss (i) | - | (277) |
- in other comprehensive income (i) | 382 | 112 |
Purchase(ii) | 27,376 | - |
Increase | - | 234 |
Sale | (11) | - |
Settlement | - | (89) |
Closing balance | 28,364 | 4,268 |
(Millions of Yen) | ||
For the year ended | Fair value measurement as at the end of the reporting period | |
31 March 2020 | ||
FVTOCI financial assets | FVTPL financial liabilities | |
28,364 | 4,268 | |
Opening balance | ||
Total gains or losses recognised: | 1,753 | 3 |
- in profit or loss (i) | - | 96 |
- in other comprehensive income (i) | 1,753 | (92) |
Purchase | 0 | - |
Increase | - | 20 |
Sale | (357) | - |
Settlement | - | (289) |
Closing balance | 29,761 | 4,001 |
(Thousands of U.S. Dollars (Note 2)) | ||
For the year ended | Fair value measurement as at the end of the reporting period | |
31 March 2020 | ||
FVTOCI financial assets | FVTPL financial liabilities | |
260,630 | 39,218 | |
Opening balance | ||
Total gains or losses recognised: | 16,110 | 30 |
- in profit or loss (i) | - | 878 |
- in other comprehensive income (i) | 16,110 | (848) |
Purchase | 3 | - |
Increase | - | 180 |
Sale | (3,280) | - |
Settlement | - | (2,660) |
Closing balance | 273,462 | 36,768 |
Note:
As at 31 March 2019
-
Total gains or losses included in profit or loss are included in the line item 'Other income' or 'Finance costs' in the consolidated statement of comprehensive income.
In total gains or losses included in other comprehensive income, gains or losses related to FVTOCI assets are included in
'Financial assets measured at fair value through other comprehensive income' or 'Exchange differences on translation of foreign operations' in the consolidated statement of comprehensive income. Gains or losses related to FVTPL liabilities are included in 'Exchange differences on translation of foreign operations' in the consolidated statement of comprehensive income. - On 1 June 2018, the Group invested 27,000 million yen in K.K. Pangea (KIOXIA Holdings Corporation).
- 87 -
As at 31 March 2020
-
Total gains or losses included in profit or loss are included in the line item 'Finance costs' in the consolidated statement of comprehensive income.
In total gains or losses included in other comprehensive income, gains or losses related to FVTOCI assets are included in 'Financial assets measured at fair value through other comprehensive income' or 'Exchange differences on translation of foreign operations' in the consolidated statement of comprehensive income. Gains or losses related to FVTPL liabilities are included in 'Exchange differences on translation of foreign operations' in the consolidated statement of comprehensive income.
- 88 -
(9) Fair value of financial assets and liabilities that are measured at fair value on a non-recurring
basis
- Carrying amounts and fair value
Assets
Financial assets measured at amortised cost Long-term loans to subsidiaries and affiliates Lease deposits
Total
Liabilities
Financial liabilities measured at amortised cost Long-term bank loans (excluding current portion)
Long-term guarantee deposits Total
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | ||||||
(Note 2)) | ||||||||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | ||||||
Carrying | Fair value | Carrying | Fair value | Carrying | Fair value | |||
amount | amount | amount | ||||||
8,248 | 8,742 | 80,331 | ||||||
8,676 | 8,454 | 77,685 | ||||||
5,100 | 5,100 | 5,304 | 5,304 | 48,736 | 48,736 | |||
13,348 | 13,775 | 13,758 | 14,046 | 126,421 | 129,067 | |||
327 | ||||||||
368 | 234 | 243 | 2,154 | 2,237 | ||||
7,855 | 7,665 | 2,989 | 2,974 | 27,469 | 27,331 | |||
8,183 | 8,035 | 3,224 | 3,217 | 29,622 | 29,568 |
- 89 -
- Fair value hierarchy
Level 1: Fair value derived from quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2: Fair value derived from inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices).
- Fair value of long-term loans to subsidiaries and affiliates and lease deposits are measured by the present value of future cash flows of each loan categorised according to a certain range of term and discounted by the risk-free rate, etc.
- Fair value of interest-bearing debt other than bonds is measured by the present value of future cash flows of each debt categorised according to a certain range of term, and discounted by the interest rate that reflects the remaining period to the maturity and credit risk.
Level 3: Fair value derived from inputs for the asset or liability that are not based on observable market data (unobservable inputs).
(Millions of Yen) | ||||
As at 31 March 2019 | Level 1 | Level 2 | Level 3 | Total |
Assets | ||||
Loans and receivables | ||||
Long-term loans to subsidiaries and affiliates | - | 8,676 | - | 8,676 |
Lease deposits | - | 5,100 | - | 5,100 |
Total | - | 13,775 | - | 13,775 |
Liabilities | ||||
Financial liabilities measured at amortised cost | ||||
Long-term bank loans (excluding current portion) | - | 368 | - | 368 |
Long-term guarantee deposits | - | 7,665 | - | 7,665 |
Total | - | 8,033 | - | 8,033 |
(Millions of Yen) | ||||
As at 31 March 2020 | Level 1 | Level 2 | Level 3 | Total |
Assets | ||||
Financial assets measured at amortised cost | ||||
Long-term loans to subsidiaries and affiliates | - | 8,742 | - | 8,742 |
Lease deposits | - | 5,304 | - | 5,304 |
Total | - | 14,046 | - | 14,046 |
Liabilities | ||||
Financial liabilities measured at amortised cost | ||||
Long-term bank loans (excluding current portion) | - | 243 | - | 243 |
Long-term guarantee deposits | - | 2,974 | - | 2,974 |
Total | - | 3,217 | - | 3,217 |
(Thousands of U.S. Dollars (Note 2)) | ||||
As at 31 March 2020 | Level 1 | Level 2 | Level 3 | Total |
Assets | ||||
Financial assets measured at amortised cost | ||||
Long-term loans to subsidiaries and affiliates | - | 80,331 | - | 80,331 |
Lease deposits | - | 48,736 | - | 48,736 |
Total | - | 129,067 | - | 129,067 |
Liabilities | ||||
Financial liabilities measured at amortised cost | ||||
Long-term bank loans (excluding current portion) | - | 2,237 | - | 2,237 |
Long-term guarantee deposits | - | 27,331 | - | 27,331 |
Total | - | 29,568 | - | 29,568 |
- 90 -
22. Share-based payments
The Company has a performance-based stock compensation plan (Performance Share Unit) and a stock option plan. The purpose of the plans is to increase the value of the Group and to improve the financial results of the Group by motivating members such as directors, officers, employees of the Group, as well as to retain valuable employees.
-
Performance Share Unit
① Details of transactions
The Company has adopted Performance Share Unit (PSU) for officers instead of a stock option plan since the year ended 31 March 2020. The variable number of shares will be distributed to the granted officers based on the achievement of pre-determined performance goal during the three years subsequent to the grant date. The number of distributed shares is variable from 0% to 200% based on the achievement of the performance goal that consists of consolidated sales, earnings per share (EPS) and ROE.
PSU granted to officers are accounted for as cash-settledshare-based payment transactions. Expense recorded in the consolidated statement of comprehensive income from undertaking shared-based payment transactions was 31 million yen (286 thousand U.S. dollars) for the year ended 31 March 2020.
Details of PSU that are outstanding for the year ended 31 March 2020, are as follows:
No. Number of shares Grant date Fair value at grant date (Yen)
1 | 15,500 | 1 Jul 2019 | 8,045 |
- Determination of fair value
The fair value of the PSU granted during the years ended 31 March 2020, was 8,045 yen and was determined based on the share price of the grant day.
-
Stock Option Plan
① Details of transactions
After the details and eligible members are approved at the meeting of the board of directors, options are granted to individuals on the condition that they render services over the vesting period, that is, subsequent to the grant date, if a member terminates his or her employment prior to the vesting date, the options will expire. The exercise period of the options is the period determined in each option contract. The options not exercised within this exercise period will expire. The option contract includes a clause that limits the maximum number of stock options a member can exercise each year during the exercisable periods.
Stock options granted to members are accounted for as share-settledshare-based payment transactions. Expense recorded in the consolidated statement of comprehensive income from undertaking shared-based payment transactions was 195 million yen and 125 million yen (1,153 thousand U.S. dollars) for the years ended 31 March 2019 and 2020, respectively.
Details of the stock options that are outstanding for the years ended 31 March 2019 and 2020, are as follows:
No. | Number of shares | Grant date | Expiry date | Exercise price (Yen) | Fair value at grant date | |||
(Yen) | ||||||||
10 | 8 Dec 2009 | 30 Sep 2019 | 2,215 | 2,784 | ||||
1,247,600 | ||||||||
11 | 1,225,600 | 7 Dec 2010 | 30 Sep 2020 | 1,947 | 1,861 | |||
12 | 680,800 | 17 Jan 2012 | 30 Sep 2021 | 1,616 | 1,427 | |||
13 | 560,800 | 16 Jan 2013 | 30 Sep 2022 | 1,648 | 1,707 | |||
14 | 758,800 | 15 Jan 2014 | 30 Sep 2023 | 2,846 | 3,141 | |||
15 | 582,400 | 14 Jan 2015 | 30 Sep 2024 | 3,972.5 | 3,585 | |||
16 | 460,400 | 13 Jan 2016 | 30 Sep 2025 | 4,928 | 3,407 | |||
17 | 386,800 | 17 Jan 2017 | 30 Sep 2026 | 4,839 | 3,740 | |||
18 | 40,400 | 13 Feb 2018 | 30 Sep 2027 | 5,765 | 4,009 | |||
19 | 123,600 | 2 Oct 2018 | 30 Sep 2028 | 6,590 | 6,345 | |||
20 | 20,000 | 13 Aug 2019 | 30 Sep 2029 | 8,542 | 7,645 |
- 91 -
- Determination of stock option value
The weighted-average fair value of the stock options granted during the years ended 31 March 2019 and 2020, was 6,345 yen and 7,645 yen, respectively.
In determining the expense of the stock options, the options were priced using the Black-Scholes model. The following table details the assumptions used in the Black-Scholes model for the options granted in the years ended 31 March 2019 and 2020.
Expected volatility was determined based on recent historical daily share price volatility from the grant date to the forecasted remaining period.
No. 19 | No. 20 | |
Share price at grant date (Yen) | 6,855 | 8,515 |
Exercise price (Yen) | 6,590 | 8,542 |
Expected volatility | 26.46% | 27.69% |
Expected remaining option life (Years) | 6.2 | 6.4 |
Dividends yield | 1.09 | 1.06 |
Risk free rate | (0.01%) | (0.35%) |
- 92 -
(3) The number and weighted-average exercise prices of stock options
The weighted-average exercise price of the outstanding options was 3,911 yen and 4,078 yen as at the years ended 31 March 2019 and 2020, respectively. Weighted-average remaining contractual life was 5.4 years and 4.8 years as at 31 March 2019 and 2020, respectively.
For the year ended 31 March 2019 | For the year ended 31 March 2020 | |||||||||
Weighted-average | Weighted-average | |||||||||
Number of shares | exercise price | Number of shares | exercise price | |||||||
(Yen) | (Yen) | |||||||||
Outstanding at the beginning of the period | 1,924,400 | 3,604 | 1,510,000 | 3,911 | ||||||
Granted | 123,600 | 6,590 | 20,000 | 8,542 | ||||||
Forfeited (i) | (41,600) | 4,279 | (31,200) | 5,184 | ||||||
Exercised | (453,600) | 3,527 | (328,400) | 3,888 | ||||||
Expired | (42,800) | 1,556 | (72,400) | 2,215 | ||||||
Outstanding at the end of the period | 1,510,000 | 3,911 | 1,098,000 | 4,078 | ||||||
Exercisable at the end of the period | 1,086,400 | 3,316 | 890,600 | 3,623 | ||||||
Note: | ||||||||||
(i) Stock options forfeited were due to employee retirements. | ||||||||||
Stock options exercised during the year ended 31 March 2020, were as follows: | ||||||||||
No. | Number of shares exercised | Exercise period | Weighted-average of share price at | |||||||
exercise date (Yen) | ||||||||||
10 | 16,400 | April 2019 to September 2019 | 7,936 | |||||||
11 | 25,600 | April 2019 to February 2020 | 8,181 | |||||||
12 | 23,600 | April 2019 to February 2020 | 8,080 | |||||||
13 | 13,200 | May 2019 to February 2020 | 8,393 | |||||||
14 | 34,000 | April 2019 to March 2020 | 8,093 | |||||||
15 | 44,000 | April 2019 to January 2020 | 8,074 | |||||||
16 | 101,200 | April 2019 to March 2020 | 8,077 | |||||||
17 | 54,800 | April 2019 to January 2020 | 8,039 | |||||||
18 | 9,200 | May 2019 to November 2019 | 8,169 | |||||||
19 | 6,400 | November 2019 to February 2020 | 8,730 | |||||||
Total | 328,400 | |||||||||
Note:
The number of shares exercised and the amount paid by key management personnel are 80,000 shares and 286 million yen, respectively.
Stock options exercised during the year ended 31 March 2019, were as follows:
No. | Number of shares exercised | Exercise period | Weighted-average of share price at |
exercise date (Yen) | |||
8 | 13,600 | July 2018 to September 2018 | 6,216 |
10 | 42,800 | April 2018 to February 2019 | 6,176 |
11 | 5,200 | June 2018 to November 2018 | 6,173 |
12 | 19,600 | August 2018 to February 2019 | 6,282 |
13 | 11,200 | May 2018 to March 2019 | 6,272 |
14 | 112,400 | April 2018 to March 2019 | 6,194 |
15 | 128,800 | April 2018 to February 2019 | 6,381 |
16 | 67,600 | June 2018 to February 2019 | 6,259 |
17 | 46,800 | June 2018 to March 2019 | 6,309 |
18 | 5,600 | October 2018 to November 2018 | 6,310 |
Total | 453,600 |
Note:
The number of shares exercised and the amount paid by key management personnel are 154,400 shares and 565 million yen, respectively.
- 93 -
23. Revenue
(1) Disaggregation of revenue
The relationship between the major geographical areas and the Group's revenue from continuing operations from its major products and services for the year ended 31 March 2019 and 2020 is as follows:
(Millions of Yen) | ||||||
For the year ended 31 March 2019 | Japan | Asia | Americas | Europe | Others | Total |
Life Care | ||||||
Health Care related products | 109,824 | 28,937 | 67,842 | 70,239 | 4,771 | 281,613 |
Medical related products | 19,335 | 13,154 | 21,029 | 35,394 | 2,864 | 91,775 |
Life Care total | 129,159 | 42,090 | 88,871 | 105,633 | 7,635 | 373,388 |
Information Technology | ||||||
Electronics related products | 20,606 | 114,649 | 9,155 | 2,212 | 0 | 146,623 |
Imaging related products | 11,286 | 28,624 | 598 | 415 | 1 | 40,924 |
Information Technology total | 31,892 | 143,273 | 9,753 | 2,627 | 1 | 187,546 |
Other | 2,770 | 595 | 494 | 1,016 | - | 4,875 |
Total revenue from external | 163,821 | 185,959 | 99,118 | 109,277 | 7,636 | 565,810 |
customers | ||||||
(Millions of Yen) | ||||||
For the year ended 31 March 2020 | Japan | Asia | Americas | Europe | Others | Total |
Life Care | ||||||
Health Care related products | 113,541 | 27,109 | 64,516 | 68,392 | 4,240 | 277,798 |
Medical related products | 20,647 | 13,525 | 22,160 | 37,819 | 3,101 | 97,251 |
Life Care total | 134,188 | 40,633 | 86,676 | 106,210 | 7,341 | 375,049 |
Information Technology | ||||||
Electronics related products | 17,068 | 134,515 | 9,002 | 2,071 | 1 | 162,655 |
Imaging related products | 8,845 | 23,696 | 937 | 597 | 1 | 34,076 |
Information Technology total | 25,913 | 158,211 | 9,939 | 2,667 | 1 | 196,731 |
Other | 2,944 | 561 | 579 | 683 | - | 4,766 |
Total revenue from external | 163,045 | 199,405 | 97,194 | 109,561 | 7,343 | 576,546 |
customers | ||||||
(Thousands of U.S. Dollars (Note 2)) | ||||||
For the year ended 31 March 2020 | Japan | Asia | Americas | Europe | Others | Total |
Life Care | ||||||
Health Care related products | 1,043,289 | 249,092 | 592,819 | 628,425 | 38,961 | 2,552,586 |
Medical related products | 189,715 | 124,273 | 203,620 | 347,501 | 28,495 | 893,605 |
Life Care total | 1,233,004 | 373,365 | 796,439 | 975,926 | 67,457 | 3,446,191 |
Information Technology | ||||||
Electronics related products | 156,831 | 1,236,006 | 82,712 | 19,025 | 5 | 1,494,580 |
Imaging related products | 81,275 | 217,734 | 8,612 | 5,483 | 6 | 313,109 |
Information Technology total | 238,106 | 1,453,740 | 91,324 | 24,509 | 11 | 1,807,690 |
Other | 27,048 | 5,152 | 5,318 | 6,278 | - | 43,797 |
Total revenue from external | 1,498,158 | 1,832,258 | 893,081 | 1,006,713 | 67,468 | 5,297,677 |
customers | ||||||
Note: |
Geographical areas are based on the location of the customers.
- 94 -
(2) Contract balances
Receivables from contracts with customers and contract liabilities are as follows. Contract liabilities consist mainly of advance received from customers.
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
As at 31 March 2019 | As at 31 March 2020 | As at 31 March 2020 | |
Receivables from contracts | 108,152 | 100,262 | 921,267 |
with customers | |||
Contract liabilities | 4,011 | 2,904 | 26,681 |
Note:
Revenues recognised in the years ended 31 March 2019 and 2020 that were included in the contract liability balances as at 1 April 2019 and 2020 were 2,401 million yen and 1,710 million yen (15,717 thousand U.S. dollars), respectively.
(3) Transaction price allocated to the remaining performance obligations
The Group uses the practical expedient of omitting the disclosure of information on the remaining performance obligations because it has no significant transactions with individual expected contractual terms exceeding one year. In addition, no significant financing components are included in consideration from contracts with customers.
(4) Assets recognised from the costs to obtain a contract with a customer
If the amortisation period of the assets is one year or less, the Group uses the practical expedient of recognising the incremental costs of obtaining the contract as an expense when incurred.
- 95 -
24. Revenue and expenses (excluding finance income and costs)
(1) Other income from continuing operations
The following is an analysis of the Group's other income from continuing operations:
(Millions of Yen) | (Millions of Yen) | ||
For the year ended | For the year ended | ||
31 March 2019 | 31 March 2020 | ||
Commission | 320 | 377 | |
Rent | 121 | 130 | |
Government grants | 398 | 423 | |
Gain on sale of plant, property and equipment | |||
and intangible assets | 674 | 438 | |
Insurance proceeds | 35 | 92 | |
Others | 2,227 | 1,003 | |
Total other income | 3,775 | 2,463 | |
(3) Employee benefits expense | |||
The following is an analysis of the Group's employee benefits expense from continuing operations: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
For the year ended | For the year ended | For the year ended | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Salary, bonuses and others | 121,016 | 122,370 | 1,124,417 |
Retirement benefit | |||
Defined benefit | 626 | 918 | 8,439 |
Defined contribution | 2,416 | 2,371 | 21,787 |
Retirement benefit total | 3,043 | 3,290 | 30,226 |
Share-based payments (stock option) | 195 | 157 | 1,439 |
Severance payments | 1,924 | 1,770 | 16,264 |
Others | 5,829 | 6,147 | 56,487 |
Total employee benefits expense | 132,006 | 133,734 | 1,228,834 |
(4) Foreign exchange gains or losses
Foreign exchange gains or losses include gains resulting from changes in fair value of currency derivatives.
(5) Other expenses | |||
The following is an analysis of the Group's other expenses from continuing operations: | |||
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
For the year ended | For the year ended | For the year ended | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Packaging/shipping/transportation | 11,268 | 11,318 | 103,999 |
Travel | 6,647 | 6,596 | 60,611 |
Rent | 8,056 | - | - |
Utilities | 12,160 | 11,928 | 109,600 |
Repair and maintenance | 13,378 | 13,185 | 121,152 |
Loss on sales of property, plant and equipment | 182 | 180 | 1,654 |
Loss on disposal of property, plant and | |||
equipment | 609 | 375 | 3,444 |
Others (Note) | 75,710 | 74,186 | 681,667 |
Total other expenses | 128,010 | 117,768 | 1,082,127 |
Note:
In April 2015, the U.S. Department of Justice issued a subpoena to Pentax of America, Inc. ("Pentax"), a U.S. subsidiary of the Company. The subpoena sought information with respect to duodenoscopes that Pentax and its affiliated companies manufactured and sold. The Company and Pentax cooperated with the U.S. Department of Justice ("DOJ") and responded to its requests. In April 2020, the Company and Pentax finalised a Deferred Prosecution Agreement with DOJ and the Group recorded an accrual for a fine and forfeiture totaling 4,680 million yen (43,000 thousand U.S. dollars).
- 97 -
25. Finance income and costs
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
For the year ended | For the year ended | For the year ended | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Finance income | |||
Interest income | |||
Cash and cash equivalents, financial | |||
assets measured at amortized cost | 2,763 | 3,452 | 31,715 |
Dividend income | |||
FVTOCI financial assets | 10 | 10 | 92 |
Total finance income | 2,733 | 3,461 | 31,806 |
Finance costs | |||
Interest costs | |||
Interest-bearing debt | 76 | 431 | 3,963 |
Retirement benefits liabilities | 36 | 47 | 432 |
Provisions | 18 | 18 | 164 |
Other liabilities | 262 | 116 | 1,065 |
Impairment losses | |||
Financial assets measured at amortised | |||
cost | - | 178 | 1,639 |
Total finance costs | 391 | 791 | 7,264 |
- 98 -
26. Other comprehensive income
For the years ended 31 March 2019 and 2020, items that may be reclassified subsequently to profit or loss comprise the following:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |
(Note 2)) | |||
For the year ended | For the year ended | For the year ended | |
31 March 2019 | 31 March 2020 | 31 March 2020 | |
Items that may be reclassified subsequently | |||
to profit or loss: | |||
① Exchange differences on translation of | |||
foreign operations (i) | |||
Gains (losses) arising during the year | 7,059 | (17,072) | (156,868) |
Reclassification adjustments to profit or | |||
loss for the year | (447) | 266 | 2,447 |
Total | 6,612 | (16,806) | (154,420) |
- Share of other comprehensive income of
associates | |||
Gains (losses) arising during the year | (17) | 76 | 701 |
Reclassification adjustments to profit or | |||
loss for the year | 0 | - | - |
Total | (16) | 76 | 701 |
Other comprehensive income/(loss) before | |||
tax | 6,596 | (16,729) | (153,719) |
Income tax relating to components of other | |||
comprehensive income | 124 | (203) | (1,863) |
Total other comprehensive income/(loss) | |||
(net of tax) | 6,720 | (16,932) | (155,583) |
Note: |
- 'Exchange differences on translation of foreign operations' consist of differences on foreign currency conversion for financial statements of foreign operations.
- 99 -
Deferred and current taxes on each item of other comprehensive income for the years ended 31 March 2019 and 2020, are as follows:
(Millions of Yen) | (Millions of Yen) | (Thousands of U.S. Dollars | |||||||||||
(Note 2)) | |||||||||||||
For the year ended | For the year ended | For the year ended | |||||||||||
31 March 2019 | 31 March 2020 | 31 March 2020 | |||||||||||
Total | Tax | Net of tax | Total | Tax | Net of tax | Total | Tax | Net of tax | |||||
Other comprehensive | |||||||||||||
income attributable to | |||||||||||||
owners of the Company | |||||||||||||
① FVTOCI financial assets | 839 | (142) | 697 | 949 | (234) | 715 | 8,720 | (2,149) | 6,571 | ||||
② Exchange differences on | |||||||||||||
translation of foreign | |||||||||||||
operations | 6,729 | 124 | 6,853 | (16,602) | (203) | (16,805) | (152,552) | (1,863) | (154,415) | ||||
③ Remeasurements of the | |||||||||||||
net defined benefit | |||||||||||||
liability (asset) | (293) | (10) | (303) | (50) | 22 | (29) | (463) | 200 | (263) | ||||
④ Share of other | |||||||||||||
comprehensive income | |||||||||||||
of associates | (16) | - | (16) | 76 | - | 76 | 701 | - | 701 | ||||
Subtotal | 7,259 | (28) | 7,231 | (15,627) | (415) | (16,042) | (143,593) | (3,812) | (147,406) | ||||
Other comprehensive | |||||||||||||
income attributable to non | |||||||||||||
-controlling interests | |||||||||||||
① FVTOCI financial assets | (30) | 7 | (23) | (16) | - | (16) | (150) | - | (150) | ||||
② Exchange differences on | |||||||||||||
translation of foreign | |||||||||||||
operations | (117) | - | (117) | (203) | - | (203) | (1,869) | - | (1,869) | ||||
Subtotal | (147) | 7 | (140) | (220) | - | (220) | (2,019) | - | (2,019) | ||||
Total other comprehensive | |||||||||||||
income/(loss) | 7,113 | (21) | 7,091 | (15,847) | (415) | (16,262) | (145,612) | (3,812) | (149,424) | ||||
- 100 -
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Hoya Corporation published this content on 11 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 September 2020 06:04:09 UTC